Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis
Open accessAbstract
A large array of studies have investigated peripheral oxytocin (OT) and vasopressin (ADH) as potential biomarkers of psychiatric disorders, with highly conflicting and heterogenous findings. We searched Web of KnowledgeSM and Scopus® for English original articles investigating OT and/or ADH levels in different biological fluids (plasma/serum, saliva, urine and cerebrospinal fluid) across several psychiatric disorders. Sixty-four studies were included. We conducted 19 preliminary meta-analyses addressing OT alterations in plasma/serum, saliva, urine and cerebrospinal fluid of 7 psychiatric disorders and ADH alterations in plasma/serum, saliva, urine and cerebrospinal fluid of 6 psychiatric disorders compared to controls. Hedge's g was used as effect size measure, together with heterogeneity analyses, test of publication biases and quality control. None of them (except serum OT in anorexia nervosa) revealed significant differences. There is no convincing evidence that peripheral ADH or OT might be reliable biomarkers in psychiatric disorders. However, the lack of significant results was associated with high methodological heterogeneity, low quality of the studies, small sample size, and scarce reliability of the methods used in previous studies, which need to be validated and standardized.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and preliminary meta-analysis found no convincing evidence that peripheral oxytocin or vasopressin levels are reliable biomarkers across psychiatric disorders. The only Bonferroni-corrected significant difference was lower serum oxytocin in anorexia nervosa, amid high heterogeneity and methodological limitations.
Key findings
- Across 19 preliminary meta-analyses, none except serum OT in anorexia nervosa showed significant differences after correction: AN serum OT n=2, overall sample=71, Hedges’ g=−0.824, 95% CI −1.308 to −0.341, p corr=0.001.
- Several uncorrected signals did not survive Bonferroni correction: CSF OT in OCD g=0.599 (p unc=0.004, p corr=ns); CSF ADH in AN g=0.922 (p unc=0.008, p corr=ns); CSF ADH in OCD g=0.601 (p unc=0.003, p corr=ns); plasma ADH in psychosis g=−0.554 (p unc=0.008, p corr=ns); salivary OT in ASD g=−0.354 (p unc=0.046, p corr=ns).
- Heterogeneity was often substantial or considerable, e.g. plasma OT in ASD Q=64.613, I²=93.81, p<0.001; plasma ADH in psychosis Q=55.984, I²=82.14, p<0.001.
- In psychosis plasma ADH, extraction technique mattered: extracted studies n=6, overall sample=220, Hedges’ g=−1.099, 95% CI −1.617 to −0.581, p=0.001, Q=13.626, I²=63.31, p=0.018.
Methods
- Systematic search of Web of Knowledge and Scopus until March 1, 2015, plus manual reference search; English original articles with ICD/DSM psychiatric diagnosis, healthy comparison group, and peripheral OT/ADH in plasma/serum, saliva, urine, or CSF; MOOSE guidelines adopted.
- Sixty-four studies were included (final database 64 samples); 19 preliminary meta-analyses were performed; diagnoses with only one study available were not meta-analyzed.
- Hedges’ g effect sizes with random-effects models, Bonferroni correction (0.05 divided by number of meta-analyses), Q and I² heterogeneity, Duval and Tweedie trim-and-fill publication bias testing, sensitivity analyses, and adapted Newcastle-Ottawa Scale quality assessment.
Limitations
- The paper states subgroups were very small, studies were highly heterogeneous, and confounders were common: 38% of included studies reported lithium salts, 42/62 (68%) failed to control for alcohol intake, 70% (35/50) did not ascertain pregnancy, and only 18% of OT studies and no ADH studies analyzed menstrual cycle fluctuations; meta-regressions were not possible due numerical constraints.
- The paper states study quality was low: Newcastle-Ottawa Scale scores ranged from 1 to 7, median 4 out of 9, and meta-analytical estimates were preliminary with high uncertainty.
- Evident from the text: many meta-analyses pooled only 2 studies; urine and saliva ADH meta-analyses were not performed because insufficient data were retrieved; the effect of NOS scores on findings could not be directly assessed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 31 cited sources checked · 0 supported · 0 flagged
- Findingown data
In plasma/serum OT, there was no difference between healthy comparisons and Psychosis (n=8, overall sample=691, Hedges' g=-0.005, 95% CI -0.304 to 0.294, p unc=0.974, substantial between-studies heterogeneity Q=24.923, I2=71.91, p=0.001).
“Psychosis (n ¼8, overall sample ¼691, Hedges' g¼ À0.005, 95% CI from À0.304 to 0.294, p unc ¼0.974, substantial between studies heterogeneity Q ¼24.923,I 2 ¼ 71.91, p¼ 0.001)”
Quote in the paperSubstantial claim - Findingown data
In CSF OT, there were no differences between healthy comparisons and BN (n=2, overall sample=86, Hedges' g=-0.219, 95% CI -0.755 to 0.318, p unc=0.425, between-studies heterogeneity non-significant).
“BN (n¼ 2, overall sample¼86, Hedges' g¼ À0.219, 95% CI from À 0.755 to 0.318, p unc¼0.425, between studies heterogeneity non-significant)”
Quote in the paperNot a substantial claim - Findingown data
In saliva OT, ASD were not statistically different from healthy controls after correction (n=2, overall sample=152, Hedges' g=-0.354, 95% CI -0.701 to -0.006, p unc=0.046, p corr=ns, between-studies heterogeneity non-significant).
“OT levels in saliva of ASD were not statistically different from those observed in healthy controls (n ¼2, overall sample ¼152, Hedges' g¼ À0.354, 95% CI from À 0.701 to À 0.006, p unc¼ 0.046, p corr ¼ ns, between studies heterogeneity non significant).”
Quote in the paperSubstantial claim - Findingown data
Patients with AN had lower serum OT levels than healthy comparisons (n=2, overall sample=71, Hedges' g=-0.824, 95% CI -1.308 to -0.341, p corr=0.001, between-studies heterogeneity non-significant).
“Patients with AN had lower serum OT levels than healthy comparisons (n¼ 2, overall sample ¼71, Hedges' g¼ À0.824, 95% CI from À 1.308 to À 0.341, p corr¼ 0.001, between studies heterogeneity non-significant).”
Quote in the paperSubstantial claim - Findingown data
In CSF OT, there were no differences between healthy comparisons and AN (n=2, overall sample=52, Hedges' g=-0.034, 95% CI -1.068 to 1.019, p unc=0.950, between-studies heterogeneity non-significant).
“We found no differences between healthy comparisons and AN (n¼2, overall sample¼52, Hedges' g¼ À0.034, 95% CI from À 1.068 to 1.019, p unc¼0.950, between studies heterogeneity non-significant)”
Quote in the paperNot a substantial claim
- Findingown data
In CSF OT, there were no differences between healthy comparisons and Psychosis (n=3, overall sample=147, Hedges' g=0.287, 95% CI -0.330 to 0.903, p unc=0.362, substantial between-studies heterogeneity Q=6.482, I2=69.14, p=0.039).
“Psychosis (n¼3, overall sample¼147, Hedges' g¼0.287, 95% CI from À 0.330 to 0.903, p unc¼ 0.362, substantial between studies heterogeneity Q¼6.482,I 2 ¼69.14, p¼0.039)”
Quote in the paperNot a substantial claim - Findingown data
In CSF OT, there were no differences between healthy comparisons and OCD after correction (n=2, overall sample=99, Hedges' g=0.599, 95% CI 0.194 to 1.004, p unc=0.004, p corr=ns, between-studies heterogeneity non-significant).
“OCD (n¼ 2, overall sample¼99, Hedges' g¼0.599, 95% CI from 0.194 to 1.004, p unc¼0.004, p corr¼ns, between studies heterogeneity non-significant)”
Quote in the paperNot a substantial claim - Findingown data
In CSF OT, there were no differences between healthy comparisons and MDD (n=2, overall sample=75, Hedges' g=-0.333, 95% CI -0.781 to 0.114, p unc=0.144, between-studies heterogeneity non-significant).
“MDD (n¼ 2, overall sample¼75, Hedges' g¼ À0.333, 95% CI from À0.781 to 0.114, p unc¼0.144, between studies heterogeneity non-significant)”
Quote in the paperNot a substantial claim - Findingown data
In plasma/serum OT, there was no difference between healthy comparisons and ASD (n=4, overall sample=404, Hedges' g=-0.576, 95% CI -1.442 to 0.291, p unc=0.193, considerable between-studies heterogeneity Q=64.613, I2=93.81, p<0.001).
“ASD (n ¼4, overall sample ¼404, Hedges' g¼ À0.576, 95% CI from À 1.442 to 0.291, p unc ¼0.193, considerable between studies heterogeneity Q¼ 64.613,I 2 ¼93.81, p o0.001)”
Quote in the paperSubstantial claim - Findingown data
In plasma/serum OT, there was no difference between healthy comparisons and BD (n=3, overall sample=275, Hedges' g=0.056, 95% CI -0.845 to 0.957, p unc=0.903, considerable between-studies heterogeneity Q=20.796, I2=90.38, p<0.001).
“BD (n¼ 3, overall sample ¼275, Hedges' g¼ 0.056, 95% CI from À 0.845 to 0.957, p unc ¼0.903, considerable between studies heterogeneity Q ¼20.796,I 2 ¼90.38, po 0.001)”
Quote in the paperSubstantial claim - Findingown data
In 19 preliminary meta-analyses, none except serum OT in anorexia nervosa revealed significant differences between patients and controls.
“None of them (except serum OT in anorexia nervosa) revealed significant differences.”
Quote in the paperSubstantial claim - Findingown data
Overall, we found no convincing evidence that either plasmatic or CSF ADH and OT levels are altered in Psychosis.
“Overall, we found no convincing evidence that either plasmatic or CSF ADH and OT levels are altered in Psychosis.”
Quote in the paperSubstantial claim - Findingown data
We found no meta-analytical evidence for peripheral ADH differences between first episode and chronic Psychosis.
“However, we found no meta-analytical evidence for peripheral ADH differences between first episode and chronic Psychosis.”
Quote in the paperSubstantial claim - Findingown data
In CSF ADH, there were no differences between healthy comparisons and MDD (n=3, overall sample=197, Hedges' g=-0.035, 95% CI -0.313 to 0.243, p unc=0.807, between-studies heterogeneity non-significant).
“MDD (n¼3, overall sample¼197, Hedges' g¼ À0.035, 95% CI from À .313 to 0.243, p unc¼ 0.807, between studies heterogeneity non-significant)”
Quote in the paperSubstantial claim - Findingown data
In plasma/serum ADH, there were no differences between healthy comparisons and MDD (n=6, overall sample=423, Hedges' g=-0.341, 95% CI -0.078 to 0.759, p unc=0.111, substantial between-studies heterogeneity Q=19.078, I2=73.79, p<0.001).
“MDD (n ¼6, overall sample ¼423, Hedges' g¼ À0.341, 95% CI from À 0.078 to 0.759, p unc ¼0.111, substantial between studies heterogeneity Q ¼19.078,I 2 ¼ 73.79, p o0.001)”
Quote in the paperSubstantial claim - Findingown data
In CSF ADH, there were no differences between healthy comparisons and Psychosis (n=2, overall sample=105, Hedges' g=0.033, 95% CI -0.424 to 0.491, p unc=0.886, between-studies heterogeneity non-significant).
“Psychosis (n¼ 2, overall sample¼ 105, Hedges' g¼0.033, 95% CI from À0.424 to 0.491, p unc¼ 0.886, between studies heterogeneity nonsignificant)”
Quote in the paperSubstantial claim - Findingown data
In Psychosis, ADH levels were significantly lower in the group of studies employing peptide extraction (n=6, overall sample=220, Hedges' g=-1.099, 95% CI -1.617 to -0.581, p=0.001, considerable between-studies heterogeneity Q=13.626, I2=63.31, p=0.018).
“ADH levels resulted significantly impaired in Psychosis (n ¼6, overall sample ¼220, Hedges' g¼ À1.099, 95% CI from À1.617 to À 0.581, p ¼0.001, considerable between studies heterogeneity Q ¼13.626,I 2 ¼63.31, p¼ 0.018) only in the group of studies employing peptide extraction”
Quote in the paperSubstantial claim - Findingown data
In plasma/serum ADH, there were no differences between healthy comparisons and BD (n=2, overall sample=193, Hedges' g=0.074, 95% CI -0.850 to 0.998, p unc=0.875, considerable between-studies heterogeneity Q=7.809, I2=87.20, p=0.005).
“BD (n ¼2, overall sample ¼ 193, Hedges' g¼0.074, 95% CI from À 0.850 to 0.998, p unc ¼0.875, considerable between studies heterogeneity Q ¼7.809,I 2 ¼87.20, p ¼0.005)”
Quote in the paperSubstantial claim - Findingown data
In CSF ADH, there were no differences between healthy comparisons and OCD after correction (n=2, overall sample=99, Hedges' g=0.601, 95% CI 0.198 to 1.003, p unc=0.003, p corr=ns, between-studies heterogeneity non-significant).
“OCD (n¼2, overall sample¼99, Hedges' g¼ 0.601, 95% CI from 0.198 to 1.003, p unc¼0.003, p corr¼ns, between studies heterogeneity non significant)”
Quote in the paperNot a substantial claim - Findingown data
In plasma/serum ADH, there were no differences between healthy comparisons and ASD (n=3, overall sample=268, Hedges' g=-0.086, 95% CI -0.992 to 0.820, p unc=0.853, considerable between-studies heterogeneity Q=23.590, I2=91.52, p<0.001).
“ASD (n¼3, overall sample ¼268, Hedges' g¼ À0.086, 95% CI from À 0.992 to 0.820, p unc¼ 0.853, considerable between studies heterogeneity Q ¼23.590,I 2 ¼91.52, p o0.001)”
Quote in the paperNot a substantial claim - Findingown data
In CSF ADH, there were no differences between healthy comparisons and AN after correction (n=2, overall sample=66, Hedges' g=0.922, 95% CI 0.243 to 1.602, p unc=0.008, p corr=ns, between-studies heterogeneity non-significant).
“AN (n¼ 2, overall sample¼66, Hedges' g¼0.922, 95% CI from 0.243 to 1.602, p unc¼0.008, p corr¼ ns, between studies heterogeneity non significant)”
Quote in the paperNot a substantial claim - Findingown data
In plasma/serum ADH, there were no differences between healthy comparisons and AN (n=2, overall sample=40, Hedges' g=-0.479, 95% CI -1.508 to 0.551, p unc=0.362, between-studies heterogeneity non-significant).
“AN (n ¼2, overall sample ¼40, Hedges' g¼ À0.479, 95% CI from À 1.508 to 0.551, p unc ¼0.362; between studies heterogeneity non-significant)”
Quote in the paperNot a substantial claim - Findingown data
A difference in serum oxytocin levels could be observed between patients suffering from anorexia nervosa and healthy comparisons.
“A difference in serum OT levels could be observed between patients suffering from AN and healthy comparisons.”
Quote in the paperSubstantial claim - Findingnone given
Plasmatic and cerebrospinal fluid neuropeptide levels were not significantly altered in affective disorders (bipolar disorder and major depressive disorder) compared to matched healthy controls.
“Plasmatic and CSF neuropeptide levels were not significantly altered in affective disorders (BD and MDD) compared to matched healthy controls.”
Quote in the paperSubstantial claim - Findingown data
There was no significant between-group heterogeneity between first-episode and chronic Psychosis in peripheral ADH levels after correction (Q=6.228, df=1, p unc=0.013, p corr=ns).
“There was no significant between-group heterogeneity (Q ¼6.228, df ¼1, p unc¼ 0.013, p corr ¼ns).”
Quote in the paperNot a substantial claim - Findingown data
The current meta-analysis does not provide convincing evidence that peripheral oxytocin or vasopressin levels are altered in psychiatric disorders as compared to healthy controls.
“The current meta-analysis does not provide convincing evidence that peripheral OT or ADH levels are altered in psychiatric disorders as compared to healthy controls.”
Quote in the paperSubstantial claim - Findingown data
The meta-analysis did not detect significant alterations of vasopressin and oxytocin in obsessive-compulsive disorder and bulimia nervosa.
“Our meta-analysis did not detect significant alterations of ADH and OT in OCD and BN.”
Quote in the paperSubstantial claim - Findingown data
The meta-analysis did not find evidence that peripheral vasopressin and oxytocin levels are impaired in autism spectrum disorder.
“We did not find evidence that peripheral ADH and OT levels are impaired in ASD”
Quote in the paperSubstantial claim - Findingown data
There were no significant differences in Newcastle-Ottawa Scale scores between the subgroups (F=0.503, df=18, p=0.943).
“There were no significant differences in Newcastle-Ottawa Scale (NOS) scores between the subgroups (F¼0.503,df ¼ 18, p¼ 0.943).”
Quote in the paperNot a substantial claim - Findingown data
The variability in average plasmatic levels was massively explained by the use of different immunoassay and by whether or not a pre-assay sample extraction was performed.
“this variability being massively explained by the use of different immunoassay and by whether or not a pre-assay sample extraction was performed (eTable 2).”
Quote in the paperSubstantial claim - Interpretationown data
There is no convincing evidence that peripheral ADH or OT might be reliable biomarkers in psychiatric disorders.
“There is no convincing evidence that peripheral ADH or OT might be reliable biomarkers in psychiatric disorders.”
Quote in the paperSubstantial claim - Study design and conductown data
42 studies out of 62 (68%) failed to control for alcohol intake.
“Furthermore, 42 studies out of 62 (68%) failed to control for alcohol intake”
Quote in the paperNot a substantial claim - Study design and conductown data
No significant difference emerged according to peptide extraction technique in MDD (Q=0.021, df=1, p=0.884).
“No significant difference emerged according to peptide extraction technique in MDD (total between group heterogeneity Q ¼0.021, df ¼1, p¼ 0.884).”
Quote in the paperNot a substantial claim - Study design and conductcitation
Sensitivity analysis removing one study per computation when at least 5 studies were included confirmed the robustness of the OT results.
“Sensitivity analysis removing one study per computation when at least 5 studies were included confirmed the robustness of the results (Higgins and Green, 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins and Green, 2011
Not checked in the free run.
- Interpretationreasoning
We found no robust and convincing evidence for significant alterations in OT and ADH in psychiatric disorders.
“We found no robust and convincing evidence for significant alterations in the two neuropeptides in psychiatric disorders.”
Quote in the paperSubstantial claim - Study design and conductown data
Because the number of studies included in each meta-analysis was too small to perform meta-regressions, it was not possible to directly assess the effect of NOS scores on the findings.
“Unfortunately, since the number of studies included in each metaanalysis was too small to perform meta-regressions, it was not possible to directly assess the effect of NOS scores on the findings of our preliminary meta-analyses.”
Quote in the paperNot a substantial claim - Interpretationcitation
The reliability of peripheral vasopressin and oxytocin levels as biomarkers of anorexia nervosa is weakened by global hypothalamic-pituitary dysfunction, the impact of fluid and sodium restriction and purging behaviours in anorexia nervosa, and the putative role of the two hormones in the regulation of the gut-brain axis and energy homeostasis.
“The reliability of peripheral ADH and OT levels as biomarkers of AN is weakened by the global hypothalamic-pituitary dysfunction, the impact of fluid and sodium restriction and purging behaviours observed in AN and the putative role of the two hormones in the regulation of the gut brain axis and energy homeostasis (Blevins and Ho, 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Blevins and Ho, 2013 source
Not checked in the free run.
- Study design and conductown data
The majority of studies did not ascertain the pregnancy state of female participants (70%, 35 out of 50).
“The majority of studies did not ascertain the pregnancy state of female participants (70%, 35 out of 50, condition not applicable to 14 studies because of the characteristics of the sample, see eTable 3 for further details).”
Quote in the paperNot a substantial claim - Study design and conductreasoning
The studies included in the meta-analysis were highly heterogeneous.
“The studies included were highly heterogeneous.”
Quote in the paperSubstantial claim - Study design and conductown data
In the MDD subgroup, sensitivity analysis revealed that overall plasma level of ADH were affected by inclusion of Sorensen et al. (1985).
“In the MDD subgroup, sensitivity analysis revealed that overall plasma level of ADH were affected by inclusion of Sorensen et al. (1985).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Sorensen et al. (1985) source
Not checked in the free run.
- Interpretationown data
Our results provide meta-analytical confirmation for the concern about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity.
“Our results provide meta-analytical confirmation for the concern, increasingly expressed by many authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Grinevich et al., 2015
Not checked in the free run.
- cites Kagerbauer et al., 2013 source
Not checked in the free run.
- cites Leng and Ludwig, 2015
Not checked in the free run.
- Study design and conductnone given
Psychotic features were unevenly considered as exclusion criteria across the articles investigating affective disorders (bipolar disorder and major depressive disorder).
“Correspondingly, psychotic features were unevenly considered as exclusion criteria across the articles investigating affective disorders (BD and MDD).”
Quote in the paperNot a substantial claim - Premisecitation
In recent evaluations, the RIA method was shown to have low sensitivity in the majority of samples tested.
“in recent evaluations the RIA method was shown to have low sensitivity in the majority of samples tested (McCullough et al., 2013)”
Quote in the paperSubstantial claim0 of 1 sources checked- cites McCullough et al., 2013 source
Not checked in the free run.
- Premisecitation
Even in extracted samples, non-OT immunoreactive products of uncertain nature account for most of the measured immunoreactivity.
“even in extracted samples the non-OT immunoreactive products of uncertain nature account for most of the measured immunoreactivity (McCullough et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites McCullough et al., 2013 source
Not checked in the free run.
- Premisecitation
Several preclinical and clinical data provide evidence of an association between vasopressin and affective disorders (bipolar disorder and major depressive disorder).
“In contrast to the null findings shown here, several preclinical and clinical data provide evidence of the association between ADH and affective disorders (BD and MDD).”
Quote in the paperNot a substantial claim - Study design and conductown data
The Duval and Tweedie method showed that the OT results were not affected by publication biases.
“The Duval and Tweedie's method showed that the results were not affected by publication biases.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The findings should be interpreted considering that peripheral levels of oxytocin and vasopressin are unreliable proxy measures of their central activity.
“Therefore, once again our findings should be interpreted considering that peripheral levels of OT and ADH are unreliable proxy measures of their central activity.”
Quote in the paperSubstantial claim - Interpretationown data
The results align with concerns that peripheral measures are not reliable proxies of the central release and activity of oxytocin and vasopressin.
“The results align with concerns that these measures are not reliable proxies of the central release and activity of these neuropeptides.”
Quote in the paperSubstantial claim - Premisecitation
Both neuropeptide levels tend to be restored after body weight recovery.
“In fact, both neuropeptide levels end to be restored after body weight recovery (Gold et al., 1983).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Gold et al., 1983 source
Not checked in the free run.
- Premisecitation
Converging evidence from animal models of autism spectrum disorder and human studies implicates alterations in the function of the oxytocin system within autism spectrum disorder.
“in contrast with converging evidence from animal models of ASD and human studies which implicate alterations in the function of the OT system within ASD.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Grinevich et al., 2015
Not checked in the free run.
- Study design and conductown data
In the Psychosis subgroup, sensitivity analysis showed that the extraction technique could have an effect on the observed results (Q=9.490, df=1, p=0.002).
“On the contrary, in the Psychosis subgroup, sensitivity analysis showed that the extraction technique could have an effect on the observed results (total between group heterogeneity Q¼9.490, df ¼1, p ¼0.002)”
Quote in the paperNot a substantial claim - Study design and conductnone given
The subgroups in the meta-analysis were very small in sample sizes.
“The subgroups were very small in sample sizes.”
Quote in the paperNot a substantial claim
- May combine two claims. 16
- Classified as probably not a substantial claim. 23
- The quote only partly states this claim. 2
May combine two claims.
Findingown dataIn plasma/serum ADH, there were no differences between healthy comparisons and Psychosis after correction (n=11, overall sample=630, Hedges' g=-0.554, 95% CI -0.966 to -0.142, p unc=0.008, p corr=ns, considerable between-studies heterogeneity Q=55.984, I2=82.14, p<0.001).
“Psychosis (n¼ 11, overall sample ¼630, Hedges' g¼ À0.554, 95% CI from À 0.966 to À 0.142, p unc ¼0.008, p corr ¼ns, considerable between studies heterogeneity Q ¼55.984,I 2 ¼ 82.14, p o0.001)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAverage plasmatic levels within studies included in the present meta-analysis ranged from 0.64 pg/mL to 436.97 pg/mL for OT and from 0.66 pg/mL to 109.17 pg/mL for ADH.
“Average plasmatic levels within studies included in the present meta-analysis ranged from 0.64 pg/mL to 436.97 pg/mL for OT and from 0.66 pg/mL to 109.17 pg/mL for ADH”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataStudy quality scores ranged from 1 to 7 (median score was 4 out of 9 possible points).
“Study quality scores ranged from 1 to 7 (median score was 4 out of 9 possible points).”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenResults were Bonferroni-corrected for multiple testing by dividing 0.05 by the overall number of meta-analyses conducted.
“Results were Bonferroni-corrected for multiple testing, by dividing 0.05 by the overall number of meta-analyses conducted.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationPublication biases were tested with the Duval and Tweedie trim and fill method when at least 3 studies were included.
“Publication biases were tested with the Duval and Tweedie”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Duval and Tweedie, 2000 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataSensitivity analyses were conducted to investigate the influence of categorical moderators: assay technique, pregnancy, alcohol use and phase of the psychotic disorder.
“We conducted other sensitivity analyses to investigate the putative influence of several categorical moderators: assay technique, pregnancy, alcohol use and phase of the psychotic disorder.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationSensitivity analyses were performed by sequentially removing each study and re-running the analysis when at least 5 studies were included.
“To further assess the robustness of the results, we performed sensitivity analyses by sequentially removing each study and re-running the analysis, when at least 5 studies were included (Higgins and Green, 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Higgins and Green, 2011
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationMOOSE guidelines were adopted to achieve high quality of reporting.
“To achieve high quality of reporting we adopted MOOSE guidelines (Stroup et al., 2000)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Stroup et al., 2000 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationMeta-analysis of observational studies is supposed to be characterized by significant heterogeneity.
“As meta-analysis of observational studies is supposed to be characterized by significant heterogeneity, random effect models were used (Cooper et al., 2009).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cooper et al., 2009
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataAn additional sub-group analysis divided First Episode Psychosis and chronic Psychosis versus healthy comparisons.
“We performed an additional sub-group analysis dividing First Episode Psychosis (FEP) and chronic Psychosis vs healthy comparisons”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenDiscrepancies were resolved through consensus with a third researcher.
“Discrepancies were resolved through consensus with a third researcher [MR].”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationHeterogeneity among study point estimates was assessed using Q statistics and the I2 index.
“Heterogeneity among study point estimates was assessed using Q statistics (Paulson and Bazemore, 2010) and the proportion of the total variability in the effect size estimates evaluated with the I 2 index (Lipsey and Wilson, 2000).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Paulson and Bazemore, 2010 source
Not checked in the free run.
- cites Lipsey and Wilson, 2000
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe lack of significant results was associated with high methodological heterogeneity, low quality of the studies, small sample size, and scarce reliability of the methods used in previous studies.
“the lack of significant results was associated with high methodological heterogeneity, low quality of the studies, small sample size, and scarce reliability of the methods used in previous studies”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenQuality of reporting was assessed with an adapted Newcastle-Ottawa Scale.
“quality of reporting criterion (adapted Newcastle-Ottawa Scale http:// www.ohri.ca/programs/clinical_epidemiology/oxford.asp, see Supplementary material for detail)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataMeta-analyses of OT levels in urine were not performed because insufficient data were retrieved.
“Meta-analyses were not performed as insufficient data were retrieved.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA two-step literature search was conducted by two independent researchers.
“A two-step literature search was conducted by two independent researchers [GR, AS].”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationBoth the commercially available immunoassays (RIA and EIA) have high heterogeneity and questionable validity.
“Both the commercially available immunoassays (RIA and EIA) have high heterogeneity and questionable validity (McCullough et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites McCullough et al., 2013 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDuring pregnancy dramatic structural and functional changes occur in the oxytocin system of the mother's brain.
“During pregnancy dramatic structural and functional changes occur in the OT system of the mother's brain (Hillerer et al., 2014;Rocchetti et al., 2014).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningThese results indicate that peripheral oxytocin and vasopressin levels are not reliable biomarkers of bipolar disorder or major depressive disorder.
“Again these results indicate that peripheral OT and ADH levels are not reliable biomarkers of BD/MDD.”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductnone givenThese findings are characterized by high heterogeneity, various methodological limitations, and poor quality.
“These findings are characterized by high heterogeneity, various methodological limitations, and poor quality.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
Study design and conductreasoningSeveral confounding factors might have had an impact on the results.
“Several confounding factors might have had an impact on the results.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataOur results do not contradict the potential role of the two neuropeptides in mental disorders per se but do clearly suggest that peripheral levels do not reliably distinguish cases from controls.
“our results do not contradict the potential role of the two neuropeptides in mental disorders per se but do clearly suggest that peripheral levels do not reliably distinguish cases from controls.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S1 (asserted), S3 (load-bearing), S4 (based). The quote only partly states this claim.
Study design and conductown dataMeta-analyses of ADH levels in saliva and urine were not performed because insufficient data were retrieved.
“Meta-analyses were not performed as insufficient data were retrieved.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThere is considerable evidence that oxytocin and vasopressin play a role in various aspects of social behaviour.
“There is considerable evidence of a role these two neuropeptides in various aspects of social behaviour.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA body of literature has demonstrated a role for OT and ADH in functions which map on to common symptoms and behavioural deficits in psychosis and schizophrenia, in particular in the social cognition domain.
“a body of literature that has demonstrated a role for these neuropeptides in functions which map on to common symptoms and behavioural deficits in psychosis and schizophrenia, in particular in the social cognition domain (MacDonald and MacDonald, 2010).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites MacDonald and MacDonald, 2010 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe meta-analytical estimates are affected by high uncertainty and should be considered as a preliminary synthesis of the available literature.
“As a consequence, our meta-analytical estimates are affected by high uncertainty and should be considered as a preliminary synthesis of the available literature.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown dataBecause the present analysis investigates between-group differences rather than within-group effects, its results do not contradict the potential role of oxytocin and vasopressin in the symptoms of psychosis per se.
“As the present analysis investigates between-group differences, not within-group effects our results do not contradict the potential role of these neuropeptides in the symptoms of psychosis per se.”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Study design and conductown dataNo significant publication bias emerged for the ADH meta-analyses.
“No significant publication bias emerged.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPreclinical studies in rats found that systemic injection of lithium leads to a significant elevation of peripheral oxytocin levels.
“As regard OT, preclinical studies in rats found that a systemic injection of lithium leads to a significant elevation of peripheral OT levels (Cui et al., 2001;You et al., 2001).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationFor saliva and urine, estimated levels are highly discrepant and weakly correlated to plasmatic levels.
“With respect to other bodily fluids, such as saliva and urine, it has been demonstrated that the estimated levels are highly discrepant and weakly correlated to plasmatic levels (McCullough et al., 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites McCullough et al., 2013 source
Not checked in the free run.
May combine two claims.
Study design and conductown dataPatients with schizoaffective psychoses were included in some of the articles in the Psychosis subgroup (oxytocin: 6 out of 11; vasopressin: 4 out of 13).
“they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008;Rubin et al., 2014Rubin et al., , 2013Rubin et al., , 2010;;Strauss et al., 2015;Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al., 1989;Ohsawa et al., 1993;Rubin et al., 2014Rubin et al., , 2013)))”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationEIA performed without extraction yielded values two orders of magnitude greater than those in extracted samples and without correlation, due to the presence of multiple adjunctive immunoreactive products besides oxytocin.
“EIA performed without extraction yielded to values that were two orders of magnitude greater than those in extracted samples (Szeto et al., 2011) and without correlation, due to the presence of multiple adjunctive immunoreactive products besides oxytocin (Szeto et al., 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Szeto et al., 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationVasopressin is involved in the regulation of the hypothalamus-pituitary-adrenal axis, which has been found to be overactive in bipolar disorder and major depressive disorder.
“ADH is involved in the regulation of the hypothalamus-pituitary-adrenal (HPA) axis, which has been found to be overactive in BD (Cervantes et al., 2001;Daban et al., 2005) and MDD (Carroll et al., 1981;Dinan, 1994;Holsboer, 2000).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHigh levels of oxytocinase secreted by the placenta might further contribute to the final serum/plasma oxytocin levels.
“Moreover, high levels of oxytocinase secreted by the placenta might further contribute to the final serum/plasma OT levels (Nomura et al., 2005).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nomura et al., 2005 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe lack of significant association was secondary to high heterogeneity across individual studies, low quality and significant methodological limitations.
“The lack of significant association was secondary to high heterogeneity across individual studies, low quality and significant methodological limitations.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStudies investigating plasma oxytocin and vasopressin levels during the menstrual cycle in different species, including humans, found that these fluctuate across the ovarian cycle.
“Studies investigating plasma OT and ADH levels during the menstrual cycle in different species, including humans, found that these fluctuate across the ovarian cycle (Wathes and Swann, 1982).(Spruce et al., 1985).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Wathes and Swann, 1982
Not checked in the free run.
- cites Spruce et al., 1985 source
Not checked in the free run.
May combine two claims.
Study design and conductown dataOnly 18% of the studies investigating oxytocin and none of those investigating vasopressin analyzed the fluctuations of oxytocin levels across the menstrual cycle phases.
“Finally, only 18% of the studies investigating OT and none of those investigating ADH analyzed the fluctuations of OT levels across the menstrual cycle phases.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe two immunoassays are poorly correlated, thus preventing the comparison of results obtained by different research groups.
“It is evident, as others have previously suggested (Christensen et al., 2014), that the two immunoassays are poorly correlated, thus preventing the comparison of results obtained by different research groups.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Christensen et al., 2014 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data38% of the included studies reported that participants were taking lithium salts.
“38% of the included studies reported that participants were taking lithium salts (eTable 3).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAccording to the Bonferroni correction, each hypothesis has been tested at a significance level of 0.002 (CI unadjusted).
“According to the Bonferroni correction, each hypothesis has been tested at a significance level of 0.002 (CI unadjusted).”
Quote in the paperNot a substantial claim
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Some, but not all, studies have shown reduced plasma oxytocin levels in children with autism spectrum disorder.
“Some, but not all, studies have shown reduced plasma oxytocin levels in children with autism spectrum disorder.6”
From Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder (2021) · cites this paper as [6]
Section 3.2.2 (p. not available) reports a negative pooled estimate for plasma oxytocin in ASD, substantial variation between studies, and no statistically significant overall difference. Table 1 (p. not available) identifies plasma studies involving children with ASD, but the available passages do not state which individual studies found reduced levels and which did not. (LLM, conf=0.74)
Experimental — accuracy not yet measuredA recent systematic review concluded that studies using ELISA on unextracted samples have produced no convincing evidence that peripheral vasopressin or oxytocin might be reliable biomarkers in psychiatric disorders.
“A recent systematic review has concluded that studies using ELISA on unextracted samples have produced no convincing evidence that peripheral vasopressin or oxytocin might be reliable biomarkers in psychiatric disorders 135.”
From Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers (2016) · cites this paper as [135]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
MDD plasma ADH effect estimate falls outside its confidence interval
MajorThe reported Hedges' g of −0.341 is below the stated confidence interval, which runs from −0.078 to 0.759. The interval's midpoint is +0.3405, suggesting a sign error in either the estimate or the interval.
Reported -0.341 · recomputed 0.3405
“MDD (n ¼6, overall sample ¼423, Hedges' g¼ À0.341, 95% CI from À 0.078 to 0.759, p unc ¼0.111”
ASD plasma OT analysis counts four studies but lists five
MinorTable 1 lists five ASD plasma-OT samples: Modahl, Al-Ayadhi, Miller, Alabdali, and Taurines. Their sample sizes total the reported 404, but the analysis says n = 4.
“ASD (n ¼4, overall sample ¼404, Hedges' g¼ À0.576”
“(a) Taurines et al. (2014) | Germany | OT | Plasma | ASD | 36 | 19 | 10.7 | 13.6 | 0 | 0 |”
Cites
1 retracted
Gumley, A. I., Braehler, C., & MacBeth, A. M. (2014) · British Journal of Clinical Psychology · doi:10.1111/bjc.12041 · Cited by 34 · cited 3× · see citing works
“Nevertheless, a recent meta-analysis examining the effects of OT on psychotic symptoms and social cognition found weak and inconsistent evidence, mainly because of methodological limitations, similarly as the ones observed by our current analysis (Gumley et al., 2014).”
RetractedCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · cited 3× · see citing works
“To further assess the robustness of the results, we performed sensitivity analyses by sequentially removing each study and re-running the analysis, when at least 5 studies were included (Higgins and Green, 2011).”
InfluentialStroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623 · see citing works
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 2× · see citing works
“Publication biases were tested with the Duval and Tweedie “trim and fill” method (Duval and Tweedie, 2000), when at least 3 studies were included.”
Method(2000) · Cited by 9,198 · see citing works
The Handbook of Research Synthesis and Meta-Analysis
(2019) · doi:10.7758/9781610448864 · Cited by 4,553 · cited 1× · see citing works
“As meta-analysis of observational studies is supposed to be characterized by significant heterogeneity, random effect models were used (Cooper et al., 2009).”
MethodThe oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · cited 1× · see citing works
“They are released in systemic circulation through the posterior pituitary gland, where they act as hormones regulating a range of physiological functions (Gimpl and Fahrenholz, 2001; Leng et al., 2015).”
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243 · see citing works
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · cited 2× · see citing works
“, 2005) and MDD (Carroll et al., 1981; Dinan, 1994; Holsboer, 2000).”
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · cited 2× · see citing works
“…cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust behaviour (Baumgartner et al., 2008).”
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 1× · see citing works
“These neuropeptides are associated with complex social and emotional processing in healthy people which if impaired may account for some of the symptoms present in psychiatric disorders (Meyer-Lindenberg et al., 2011).”
BackgroundPaulson, J. F., & Bazemore, S. D. (2010) · JAMA · doi:10.1001/jama.2010.605 · Cited by 1,337 · cited 2× · see citing works
“Heterogeneity among study point estimates was assessed using Q statistics (Paulson and Bazemore, 2010) and the proportion of the total variability in the effect size estimates evaluated with the I(2) index (Lipsey and Wilson, 2000).”
MethodOxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298 · cited 2× · see citing works
“, 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al.”
BackgroundOxytocin shapes the neural circuitry of trust and trust adaptation in humans
Baumgartner, T., Heinrichs, M., Vonlanthen, A., Fischbacher, U., & Fehr, E. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.009 · Cited by 1,258 · cited 3× · see citing works
“, 2004) investigated peripheral levels of ADH in first-episode, drug naïve patients and eight (Beckmann et al., 1985; Elman et al., 2003; Jobst et al., 2014; Kudoh et al., 1998; Ohsawa et al., 1993; Rubin et al., 2014; Sarai and Matsunaga, 1989; Walsh et al., 2005) in chronic patients.”
BackgroundInfluentialLandgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059 · cited 2× · see citing works
“…and independent neuropeptide synthesis and vesicle routing and targeting have been shown in the somata (for peripheral secretion and somatic release) and in dendrites (for dendritic release), which might account for independent central and peripheral release patterns (Landgraf and Neumann, 2004).”
Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.020 · Cited by 962 · cited 3× · see citing works
“For example, OT alters response to social cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust…”
Dendritic peptide release and peptide-dependent behaviours
Ludwig, M., & Leng, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1845 · Cited by 945 · cited 8× · see citing works
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
BackgroundInfluentialPromoting social behavior with oxytocin in high-functioning autism spectrum disorders.
Andari, E., Duhamel, J.-R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910249107 · Cited by 941 · cited 2× · see citing works
“…Rutigliano et al. / Psychiatry Research 241 (2016) 207–220 217 domains, namely emotion recognition (Guastella et al., 2010a), social cognition (Andari et al., 2010), and core autistic repetitive behaviours (e.g. ordering, compulsion to tell/ask and touching) (Hollander et al., 2003), to…”
Oxytocin, vasopressin, and human social behavior
Heinrichs, M., von Dawans, B., & Domes, G. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.005 · Cited by 799 · cited 1× · see citing works
“An increasing number of studies have also began to dissect the roles of OT and ADH in human social behaviour (Heinrichs et al., 2009).”
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728 · cited 13× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialOxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300021 · Cited by 689 · cited 2× · see citing works
“ordering, compulsion to tell/ask and touching) (Hollander et al., 2003), to modest (Anagnostou et al.”
Intranasal Oxytocin: Myths and Delusions
Leng, G., & Ludwig, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.003 · Cited by 615 · cited 4× · see citing works
“…207 –220 215 G. Rutigliano et al. / Psychiatry Research 241 (2016) 207–220216 On the other hand plasma OT levels are stable, except in pregnancy (Leng and Ludwig, 2015), but may be regulated independently from central OT as suggested by converging evidence from animal studies (Ludwig et al.,…”
InfluentialOxytocin is associated with human trustworthiness
ZAK, P., KURZBAN, R., & MATZNER, W. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.07.009 · Cited by 595 · cited 2× · see citing works
“For example, OT alters response to social cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust…”
The Peptide That Binds: A Systematic Review of Oxytocin and its Prosocial Effects in Humans
MacDonald, K., & MacDonald, T. M. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673220903523615 · Cited by 585 · cited 5× · see citing works
“Further, peptides appear to have a short plasma half-life (1–2 min) and a slightly longer central half-life ( 30 min) (MacDonald and MacDonald, 2010).”
InfluentialPlasma oxytocin increases in the human sexual response
CARMICHAEL, M. S., HUMBERT, R., DIXEN, J., PALMISANO, G., GREENLEAF, W., & DAVIDSON, J. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-27 · Cited by 554 · cited 2× · see citing works
“Originally, ADH and OT have been described as hormones, involved respectively in antidiuresis, osmolality regulation, direct vasoconstriction and hepatic glycogenolysis (Appelgren, 1982; Robertson, 2001) and labor (Husslein, 1984), lactation (Crowley, 2015), and sexual activity (Carmichael et al., 1987).”
Neuromodulation by Oxytocin and Vasopressin
Stoop, R. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.025 · Cited by 506 · cited 2× · see citing works
“They are also released in the central nervous system, acting on multiple brain regions as neuromodulators and influencing a range of neurophysiological processes and behaviours (Stoop, 2012), including feeding, anxiety, aggression, social recognition and the stress/fear response to social stimuli (Hashimoto et al.”
Walum, H., Westberg, L., Henningsson, S., Neiderhiser, J. M., Reiss, D., Igl, W., Ganiban, J. M., Spotts, E. L., Pedersen, N. L., Eriksson, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803081105 · Cited by 460 · see citing works
Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?
McCullough, M. E., Churchland, P. S., & Mendez, A. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.018 · Cited by 416 · see citing works
Vasopressin V1b receptor knockout reduces aggressive behavior in male mice
Wersinger, S. R., Ginns, E. I., O'Carroll, A.-M., Lolait, S. J., & Young III, W. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001195 · Cited by 397 · cited 2× · see citing works
“Axonal and dendritic/soma release may be independently regulated by the MCNs through inhibitory mechanisms – mediated by corticosterone, GABA, endogenous opioids, the atrial natriuretic peptide and ADH itself – which selectively block the peripheral secretion (Wotjak et al., 1998).”
BackgroundMens, W. B. J., Witter, A., & Van Wimersma Greidanus, T. B. (1983) · Brain Research · doi:10.1016/0006-8993(83)90478-x · Cited by 360 · cited 1× · see citing works
“Furthermore, the blood-brain barrier prevents ADH and OT to reflow into the central compartment (i. e. brain parenchyma and CSF) once they have reached the peripheral one (i. e., blood and peripheral organs) (Kagerbauer et al., 2013; Mens et al., 1983).”
Anagnostou, E., Soorya, L., Chaplin, W., Bartz, J., Halpern, D., Wasserman, S., Wang, A. T., Pepa, L., Tanel, N., Kushki, A., et al. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-16 · Cited by 350 · see citing works
Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites
Ludwig, M., Sabatier, N., Bull, P. M., Landgraf, R., Dayanithi, G., & Leng, G. (2002) · Nature · doi:10.1038/nature00822 · Cited by 346 · cited 2× · see citing works
“Priming persisting for at least 90 min (Ludwig et al., 2002) allows peptides to survive for long enough to diffuse to distant sites.”
Wotjak, C. T., Ganster, J., Kohl, G., Holsboer, F., Landgraf, R., & Engelmann, M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00683-0 · Cited by 345 · cited 1× · see citing works
“Axonal and dendritic/soma release may be independently regulated by the MCNs through inhibitory mechanisms – mediated by corticosterone, GABA, endogenous opioids, the atrial natriuretic peptide and ADH itself – which selectively block the peripheral secretion (Wotjak et al., 1998).”
Rilling, J. K., DeMarco, A. C., Hackett, P. D., Chen, X., Gautam, P., Stair, S., Haroon, E., Thompson, R., Ditzen, B., Patel, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.022 · Cited by 343 · cited 2× · see citing works
“ADH has been shown to alter reciprocation of cooperation in males (Rilling et al., 2014) while the ADH Avpr-1a gene, which is involved in social bonding in humans (Walum et al., 2008), has been shown to influence the money people will give to others in an economic game (Knafo et al., 2008).”
Central vasopressin and oxytocin release: regulation of complex social behaviours
VEENEMA, A., & NEUMANN, I. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00422-6 · Cited by 338 · cited 2× · see citing works
“intracerebral microdialysis (Veenema and Neumann, 2008), targeted delivery of neuropeptide agonists or antagonists (Song et al.”
Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model
Dinan, T. G. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.3.365 · Cited by 338 · cited 2× · see citing works
“, 2005) and MDD (Carroll et al., 1981; Dinan, 1994; Holsboer, 2000).”
Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin
Szeto, A., McCabe, P. M., Nation, D. A., Tabak, B. A., Rossetti, M. A., McCullough, M. E., Schneiderman, N., & Mendez, A. J. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31821df0c2 · Cited by 330 · see citing works
Sex-specific influences of vasopressin on human social communication
Thompson, R. R., George, K., Walton, J. C., Orr, S. P., & Benson, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600406103 · Cited by 312 · cited 16× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialAssembling the puzzle: pathways of oxytocin signaling in the brain
Grinevich, V., Knobloch-Bollmann, H. S., Eliava, M., Busnelli, M., & Chini, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.013 · Cited by 309 · cited 3× · see citing works
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients
Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308 · cited 2× · see citing works
“…of two recent clinical trials of exogenous OT (intranasal administration; dose: 24 IU twice daily (Pedersen et al., 2011) and 40 IU twice daily (Feifel et al., 2010)) in patients with schizophrenia suggest a therapeutic effect across different symptom domains with good safety and tolerability…”
Pedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.027 · Cited by 305 · cited 2× · see citing works
“Finally, the results of two recent clinical trials of exogenous OT (intranasal administration; dose: 24 IU twice daily (Pedersen et al., 2011) and 40 IU twice daily (Feifel et al.”
Knafo, A., Israel, S., Darvasi, A., Bachner‐Melman, R., Uzefovsky, F., Cohen, L., Feldman, E., Lerer, E., Laiba, E., Raz, Y., et al. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00341.x · Cited by 294 · cited 2× · see citing works
“ADH has been shown to alter reciprocation of cooperation in males (Rilling et al., 2014) while the ADH Avpr-1a gene, which is involved in social bonding in humans (Walum et al., 2008), has been shown to influence the money people will give to others in an economic game (Knafo et al., 2008).”
Is oxytocin an ovarian hormone?
Wathes, D. C., & Swann, R. W. (1982) · Nature · doi:10.1038/297225a0 · Cited by 266 · cited 1× · see citing works
“Studies investigating plasma OT and ADH levels during the menstrual cycle in different species, including humans, found that these fluctuate across the ovarian cycle (Wathes and Swann, 1982).”
Hypothalamic-pituitary-adrenal axis and bipolar disorder
Daban, C., Vieta, E., Mackin, P., & Young, A. H. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.005 · Cited by 245 · cited 2× · see citing works
“ADH is involved in the regulation of the hypothalamus-pituitary-adrenal (HPA) axis, which has been found to be overactive in BD (Cervantes et al., 2001; Daban et al., 2005) and MDD (Carroll et al., 1981; Dinan, 1994; Holsboer, 2000).”
Uzunova, G., Pallanti, S., & Hollander, E. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1085597 · Cited by 242 · cited 1× · see citing works
“…there is also growing interest in the potential for synthetic neuropeptides in treatment of psychosis (for a comprehensive review see (Gumley et al., 2014)), autism spectrum disorders (ASD) (Thompson et al., 2006; Uzunova et al., 2015), and affective and anxiety disorders (Griebel et al., 2012).”
The psychobiology of emotion: the role of the oxytocinergic system
Uvnäs-Moberg, K., Arn, I., & Magnusson, D. (2005) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1202_3 · Cited by 238 · cited 1× · see citing works
“Also long-lasting changes induced in other transmitter systems may further extend their biological activity and behavioural effects (MacDonald and MacDonald, 2010; Uvanas-Moberg et al., 2005).”
BackgroundPeripheral oxytocin is associated with reduced symptom severity in schizophrenia
Rubin, L. H., Carter, C. S., Drogos, L. L., Pournajafi‐Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.014 · Cited by 228 · cited 3× · see citing works
“, 2009) and OT levels have been shown to correlate inversely with symptomatology (including suspiciousness and paranoia) and prosociality (Rubin et al., 2010), as well as capacity to identify facial emotions (Goldman et al.”
Ryan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225 · cited 2× · see citing works
“Three studies (Emsley et al., 1989; Rubin et al., 2013; Ryan et al., 2004) investigated peripheral levels of ADH in first-episode, drug naïve patients and eight (Beckmann et al., 1985; Elman et al., 2003; Jobst et al., 2014; Kudoh et al., 1998; Ohsawa et al., 1993; Rubin et al., 2014; Sarai and…”
Release of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats
Moos, F., Poulain, D. A., Rodriguez, F., Guern�, Y., Vincent, J. D., & Richard, P. (1989) · Experimental Brain Research · doi:10.1007/bf00248916 · Cited by 221 · cited 2× · see citing works
“…et al. / Psychiatry Research 241 (2016) 207–220216 On the other hand plasma OT levels are stable, except in pregnancy (Leng and Ludwig, 2015), but may be regulated independently from central OT as suggested by converging evidence from animal studies (Ludwig et al., 1994; Moos et al., 1989).”
Oxytocin Levels in Social Anxiety Disorder
Hoge, E. A., Pollack, M. H., Kaufman, R. E., Zak, P. J., & Simon, N. M. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00051.x · Cited by 213 · cited 1× · see citing works
“…2014; Turan et al., 2013), major depressive disorder (MDD) (Goldstein et al., 2000; Ozsoy et al., 2009; Yuen et al., 2014), as well as in anxiety (Hoge et al., 2012, 2008), personality (Bertsch et al., 2013) and eating disorders (anorexia nervosa, AN and bulimia nervosa, BN) (Frank et al., 2000;…”
Kagerbauer, S. M., Martin, J., Schuster, T., Blobner, M., Kochs, E. F., & Landgraf, R. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12038 · Cited by 212 · cited 4× · see citing works
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
InfluentialGoldman, M. B., Marlow-O’Connor, M., Torres, I. J., & Carter, C. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.019 · Cited by 211 · cited 5× · see citing works
“…in the trust-related increases in OT seen in controls (Keri et al., 2009) and OT levels have been shown to correlate inversely with symptomatology (including suspiciousness and paranoia) and prosociality (Rubin et al., 2010), as well as capacity to identify facial emotions (Goldman et al., 2008).”
InfluentialLeckman, J. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100030003 · Cited by 209 · cited 2× · see citing works
“…social anxiety (GSAD) (Hoge et al., 2012), borderline personality disorder (BPD) (Bertsch et al., 2013), attention deficit and hyperactivity disorder (ADHD) (Taurines et al., 2014), Tourette syndrome (TS) (Leckman et al., 1994) and Prader-Willi syndrome (PWS) (Martin et al., 1998) (eTable 4).”
InfluentialRobertson, G. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70207-3 · Cited by 207 · cited 2× · see citing works
“…ADH and OT have been described as hormones, involved respectively in antidiuresis, osmolality regulation, direct vasoconstriction and hepatic glycogenolysis (Appelgren, 1982; Robertson, 2001) and labor (Husslein, 1984), lactation (Crowley, 2015), and sexual activity (Carmichael et al., 1987).”
Pagani, J. H., Zhao, M., Cui, Z., Williams Avram, S. K., Caruana, D. A., Dudek, S. M., & Young, W. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.47 · Cited by 204 · cited 2× · see citing works
“, 2002), and viral gene transfer (Pagani et al., 2014)).”
Gold, P. W., Kaye, W., Robertson, G. L., & Ebert, M. (1983) · New England Journal of Medicine · doi:10.1056/nejm198305123081902 · Cited by 192 · cited 3× · see citing works
“…CSF Antidiuretic Hormone in Obsessive-Compulsive Disorder Altemus et al. (1992a) 3 ⋆ / / ⋆ / / ⋆ / (b) Leckman et al. (1994) 5 ⋆ / / / ⋆⋆ ⋆ ⋆ / Overall 4.00 (71.414) CSF Antidiuretic Hormone in Anorexia Nervosa (a) Gold et al. (1983) 2 / / / / ⋆ / ⋆ / (c) Frank et al. (2000) 6 ⋆ / ⋆ ⋆ ⋆⋆ /…”
BackgroundInfluentialReduced plasma oxytocin levels in female patients with borderline personality disorder
Bertsch, K., Schmidinger, I., Neumann, I. D., & Herpertz, S. C. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.11.013 · Cited by 189 · cited 4× · see citing works
“, 2012), borderline personality disorder (BPD) (Bertsch et al., 2013), attention deficit and hyperactivity disorder (ADHD) (Taurines et al.”
InfluentialAltemus, M. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010009002 · Cited by 186 · cited 1× · see citing works
“…al. (1998) 3 / / / / ⋆⋆ / ⋆ / Elman et al. (2003) 5 ⋆ / ⋆ ⋆ / / ⋆ ⋆ Ryan et al. (2004) 6 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ / Walsh et al. (2005) 5 ⋆ / / ⋆ ⋆ ⋆ ⋆ / (b) Rubin et al. (2013) 6 ⋆ ⋆ ⋆ ⋆ ⋆ / ⋆ / (b) Jobst et al. (2014) 4 ⋆ / / / ⋆⋆ / ⋆ / (d) Rubin et al. (2014) 7 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ ⋆ Overall 4.09 (71.814) CSF…”
InfluentialThe effects of vasopressin on human facial responses related to social communication
Thompson, R. R., Gupta, S., Miller, K., Mills, S. D., & Orr, S. P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00133-6 · Cited by 184 · cited 2× · see citing works
“Research with ADH in human social cognition is less prevalent but there is evidence that intranasal ADH biases emotional face perception (Thompson et al., 2004)), enhances memory encoding of human faces (Guastella et al.”
Özsoy, S., Eşel, E., & Kula, M. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.034 · Cited by 168 · cited 20× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialSharing secrets: oxytocin and trust in schizophrenia
Kéri, S., Kiss, I., & Kelemen, O. (2009) · Social Neuroscience · doi:10.1080/17470910802319710 · Cited by 167 · cited 2× · see citing works
“In schizophrenia, patients have been shown to produce a failure in the trust-related increases in OT seen in controls (Keri et al., 2009) and OT levels have been shown to correlate inversely with symptomatology (including suspiciousness and paranoia) and prosociality (Rubin et al., 2010), as well…”
Circadian secretion of cortisol in bipolar disorder.
Cervantes, P., Gelber, S., Kin, F. N. K. N. Y., Nair, V. N. P., & Schwartz, G. J. (2001) · PubMed Central · Cited by 163 · see citing works
Stimuli and consequences of dendritic release of oxytocin within the brain
Neumann, I. D. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351252 · Cited by 161 · cited 2× · see citing works
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
Anagnostou, E., Soorya, L., Brian, J., Dupuis, A., Mankad, D., Smile, S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.049 · Cited by 155 · cited 2× · see citing works
“, 2012) or null clinical improvement (Anagnostou et al., 2014).”
Merali, Z., Kent, P., Du, L., Hrdina, P. D., Palkovits, M., Faludi, G., Poulter, M. O., Bédard, T., & Anisman, H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.008 · Cited by 155 · cited 5× · see citing works
“Postmortem brain tissues of patients with MDD and BD contain a greater number of ADH-immunoreactive neurons in the hypothalamic PVN (Merali et al., 2006).”
BackgroundInfluentialLudwig, M., Callahan, M. F., Neumann, I. D., Landgraf, R., & Morris, M. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00595.x · Cited by 155 · cited 2× · see citing works
“…et al. / Psychiatry Research 241 (2016) 207–220216 On the other hand plasma OT levels are stable, except in pregnancy (Leng and Ludwig, 2015), but may be regulated independently from central OT as suggested by converging evidence from animal studies (Ludwig et al., 1994; Moos et al., 1989).”
Miller, M., Bales, K. L., Taylor, S. L., Yoon, J., Hostetler, C. M., Carter, C. S., & Solomon, M. (2013) · Autism Research · doi:10.1002/aur.1270 · Cited by 151 · cited 2× · see citing works
“(a) Miller et al. (2013) 2013 USA OT Plasma ASD 75 40 35 12 12.”
InfluentialLow CSF oxytocin reflects high intent in suicide attempters
Jokinen, J., Chatzittofis, A., Hellström, C., Nordström, P., Uvnäs-Moberg, K., & Åsberg, M. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.016 · Cited by 143 · cited 3× · see citing works
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
BackgroundVasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls
Beckmann, H., Lang, R. E., & Gattaz, W. F. (1985) · Psychoneuroendocrinology · doi:10.1016/0306-4530(85)90056-3 · Cited by 138 · cited 2× · see citing works
“…(1997) 4 ⋆ / / ⋆ / / ⋆ ⋆ van Londen et al. (1998) 4 ⋆ / / ⋆ / / ⋆ ⋆ Rubin et al. (1999) 5 ⋆ / / ⋆ ⋆⋆ / ⋆ / Goldstein et al. (2000) 4 ⋆ / / / ⋆ / ⋆ ⋆ Goekoop et al. (2006) 3 ⋆ / / / / / ⋆ ⋆ Overall 3.67 (71.033) CSF Antidiuretic Hormone in Psychosis (b) Beckmann et al. (1985) 3 ⋆ ⋆ / / / / ⋆ /…”
InfluentialIntranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans
Guastella, A. J., Kenyon, A. R., Alvares, G. A., Carson, D. S., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.014 · Cited by 130 · cited 3× · see citing works
“For example, OT alters response to social cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust…”
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi-Nazarloo, H., Drogos, L. L., Hill, S. K., Ruocco, A. C., Keedy, S. K., Reilly, J. L., Keshavan, M. S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu027 · Cited by 127 · cited 11× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialNeuroendocrine Regulation of Lactation and Milk Production
Crowley, W. R. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140029 · Cited by 124 · see citing works
Lawson, E. A., Donoho, D. A., Blum, J. I., Meenaghan, E. M., Misra, M., Herzog, D. B., Sluss, P. M., Miller, K. K., & Klibanski, A. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06617 · Cited by 124 · see citing works
Lawson, E. A., Holsen, L. M., Santin, M., Meenaghan, E. M., Eddy, K. T., Becker, A. E., Herzog, D. B., Goldstein, J. M., & Klibanski, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1702 · Cited by 121 · see citing works
Drug-Induced Diabetes Insipidus
Bendz, H., & Aurell, M. (1999) · Drug Safety · doi:10.2165/00002018-199921060-00002 · Cited by 120 · see citing works
The maternal brain: an organ with peripartal plasticity
Hillerer, K. M., Jacobs, V. R., Fischer, T., & Aigner, L. (2014) · Neural Plasticity · doi:10.1155/2014/574159 · Cited by 120 · see citing works
Association of social and cognitive impairment and biomarkers in autism spectrum disorders
Alabdali, A., Al-Ayadhi, L., & El-Ansary, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-4 · Cited by 117 · cited 14× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialCSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations
Demitrack, M. A., Lesem, M. D., LISTWAK, S. J., Brandt, H., Jimerson, D. C., & Gold, P. W. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.7.882 · Cited by 116 · cited 3× · see citing works
“(a) Demitrack et al. (1990) 1990 USA OT CSF AN 25 14 11 24.”
InfluentialOxytocin in schizophrenia: a review of evidence for its therapeutic effects
MacDonald, K. S., & Feifel, D. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00634.x · Cited by 111 · cited 1× · see citing works
“Administration of OT either intracerebrally or subcutaneously effectively reverted behavioural deficits in rodent models of schizophrenia (Macdonald and Feifel, 2012).”
BackgroundSong, Z., McCann, K. E., McNeill, J. K., Larkin, T. E., Huhman, K. L., & Albers, H. E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.005 · Cited by 111 · cited 1× · see citing works
“…manipulate central OT and ADH levels and their effects on behaviour (e.g. intracerebral microdialysis (Veenema and Neumann, 2008), targeted delivery of neuropeptide agonists or antagonists (Song et al., 2014), gene knockout (Wersinger et al., 2002), and viral gene transfer (Pagani et al., 2014)).”
Role of oxytocin signaling in the regulation of body weight
Blevins, J. E., & Ho, J. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9260-x · Cited by 108 · cited 2× · see citing works
“…levels as biomarkers of AN is weakened by the global hypothalamic-pituitary dysfunction, the impact of fluid and sodium restriction and purging behaviours observed in AN and the putative role of the two hormones in the regulation of the gut brain axis and energy homeostasis (Blevins and Ho, 2013).”
Cerebrospinal-fluid vasopressin in neurological and psychiatric-disorders
Sorensen, P. S., Gjerris, A., & Hammer, M. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.1.50 · Cited by 103 · cited 19× · see citing works
“Plasma oxytocin levels in autistic children.”
InfluentialYuen, K. W., Garner, J. P., Carson, D. S., Keller, J., Lembke, A., Hyde, S. A., Kenna, H. A., Tennakoon, L., Schatzberg, A. F., & Parker, K. J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.012 · Cited by 99 · see citing works
The Role of Oxytocin in Neuropsychiatric Disorders
Marazziti, D., & Dell’Osso, M. C. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783885291 · Cited by 99 · see citing works
Silva, S. M., Madeira, M. D., Ruela, C., & Paula-Barbosa, M. M. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03261-9 · Cited by 98 · cited 2× · see citing works
“%) failed to control for alcohol intake (not applicable to 2 studies which had recruited only children), which was reported to induce degeneration in numerous neurons in the hypothalamic magnocellular system in rats (Silva et al., 2002).”
Oxytocin decreases aversion to angry faces in an associative learning task
Evans, S., Shergill, S. S., & Averbeck, B. B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.110 · Cited by 97 · cited 2× · see citing works
“, 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al.”
Sasayama, D., Hattori, K., Teraishi, T., Hori, H., Ota, M., Yoshida, S., Arima, K., Higuchi, T., Amano, N., & Kunugi, H. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.016 · Cited by 96 · cited 2× · see citing works
“%) failed to control for alcohol intake (not applicable to 2 studies which had recruited only children), which was reported to induce degeneration in numerous neurons in the hypothalamic magnocellular system in rats (Silva et al., 2002).”
BackgroundOxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients
Jobst, A., Dehning, S., Ruf, S., Notz, T., Buchheim, A., Henning-Fast, K., Meißner, D., Meyer, S., Bondy, B., Müller, N., et al. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.20 · Cited by 89 · see citing works
Cerebrospinal fluid levels of oxytocin in Prader–Willi syndrome: a preliminary report
Martin, A., State, M., Anderson, G. M., Kaye, W. M., Hanchett, J. M., McConaha, C. W., North, W. G., & Leckman, J. F. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00190-5 · Cited by 89 · cited 3× · see citing works
“, 1994) and Prader-Willi syndrome (PWS) (Martin et al., 1998) (eTable4).”
Arginine Vasopressin Is Associated with Hypercortisolemia and Suicide Attempts in Depression
Inder, W. J., Donald, R. A., Prickett, T. C. R., FRAMPTON, C. M. A., Sullivan, P. F., Mulder, R., & Joyce, P. R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00301-6 · Cited by 88 · see citing works
Parent–child interaction and oxytocin production in pre-schoolers with autism spectrum disorder
Feldman, R., Golan, O., Hirschler‐Guttenberg, Y., Ostfeld‐Etzion, S., & Zagoory‐Sharon, O. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.137513 · Cited by 86 · see citing works
Leng, G., Pineda, R., Sabatier, N., & Ludwig, M. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0087 · Cited by 85 · cited 1× · see citing works
“They are released in systemic circulation through the posterior pituitary gland, where they act as hormones regulating a range of physiological functions (Gimpl and Fahrenholz, 2001; Leng et al., 2015).”
Glovinsky, D., Kalogeras, K. T., Kirch, D. G., Suddath, R. L., & Wyatt, R. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90021-3 · Cited by 84 · see citing works
Cui, S.-S., Bowen, R. C., Gu, G.-B., Hannesson, D. K., Yu, P. H., & Zhang, X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09867.2001 · Cited by 84 · cited 1× · see citing works
“As regard OT, preclinical studies in rats found that a systemic injection of lithium leads to a significant elevation of peripheral OT levels (Cui et al., 2001; You et al., 2001).”
Rocchetti, M., Radua, J., Paloyelis, Y., Xenaki, L., Frascarelli, M., Caverzasi, E., Politi, P., & Fusar‐Poli, P. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12185 · Cited by 83 · cited 1× · see citing works
“During pregnancy dramatic structural and functional changes occur in the OT system of the mother's brain (Hillerer et al., 2014; Rocchetti et al., 2014).”
Self-citationChanges in cerebrospinal fluid neurochemistry during pregnancy
Altemus, M., Fong, J., Yang, R., Damast, S., Luine, V., & Ferguson, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.002 · Cited by 83 · cited 2× · see citing works
“In humans no correlation was found between central and plasma OT in pregnant women (Altemus et al., 2004) and suicide attempters (Jokinen et al., 2012).”
VARIATION IN OSMOREGULATION OF ARGININE VASOPRESSIN DURING THE HUMAN MENSTRUAL CYCLE
SPRUCE, B. A., BAYLIS, P. H., BURD, J., & WATSON, M. J. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01062.x · Cited by 82 · cited 1× · see citing works
“(Spruce et al., 1985).”
Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07804 · Cited by 81 · cited 3× · see citing works
“…there is also growing interest in the potential for synthetic neuropeptides in treatment of psychosis (for a comprehensive review see (Gumley et al., 2014)), autism spectrum disorders (ASD) (Thompson et al., 2006; Uzunova et al., 2015), and affective and anxiety disorders (Griebel et al., 2012).”
BackgroundMethodPitts, A. F., Samuelson, S. D., Meller, W. H., Bissette, G., Nemeroff, C. B., & Kathol, R. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00229-a · Cited by 79 · cited 1× · see citing works
“…(1977) 1 / / / / / / ⋆ / (c) Rubin et al. (2014) 7 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ ⋆ Overall 4.00 (74.243) CSF Antidiuretic Hormone in Major Depressive Disorder (a) (Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / (b) Pitts et al. (1995) 4 ⋆ / / ⋆ / / ⋆ ⋆ Heuser et al. (1998) 4 ⋆ / / ⋆ / ⋆ ⋆ / Overall 3.33 (71.155)…”
InfluentialPlasma arginine vasopressin and motor activity in major depression
van Londen, L., KERKHOF, G. A., van den Berg, F., Goekoop, J. G., Zwinderman, A. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., & de Wied, D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)80433-7 · Cited by 79 · cited 5× · see citing works
“van Londen et al. (1998) 1998 The Netherlands ADH Plasma MDD 89 52 37 44.”
InfluentialNormal CSF oxytocin and NPY levels in OCD
Altemus, M. M., Jacobson, K. R., DeBellis, M. D., Kling, M. A., Pigott, T. A., Murphy, D. L., & Gold, P. W. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00263-7 · Cited by 78 · see citing works
Bendz, H., Sjödin, I., & Aurell, M. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.3.457 · Cited by 74 · cited 1× · see citing works
“…lithium exerts adverse effects on the kidney, leading to nephrogenic diabetes insipidus (NDI) in up to 10% of the patients on long term treatment (Bendz and Aurell, 1999; Bendz et al., 1996), which may be expected to be associated with a compensatory increase in ADH release (Watson et al., 2007).”
Chang, S. W. C., & Platt, M. L. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.006 · Cited by 71 · cited 1× · see citing works
“Evidence from animal studies has demonstrated the significant role that OT and ADH play in the regulation of social behaviour and cognition (Chang and Platt, 2014).”
Altered oxytocin and vasopressin levels in autistic children in Central Saudi Arabia
AL-Ayadhi, L. Y. (2005) · Neurosciences · doi:10.17712/1658-3183.1311 · Cited by 71 · cited 2× · see citing works
“…2012, 2008), personality (Bertsch et al., 2013) and eating disorders (anorexia nervosa, AN and bulimia nervosa, BN) (Frank et al., 2000; Lawson et al., 2011, 2012), with highly heterogeneous and conflicting results (Al-Ayadhi, 2005; Alabdali et al., 2014; Emsley et al., 1989; Watson et al., 2007).”
BackgroundInfluentialChristensen, J. C., Shiyanov, P. A., Estepp, J. R., & Schlager, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116172 · Cited by 69 · cited 3× · see citing works
“Since the main methodological concern specifically regards the use of extraction (Christensen et al., 2014), we performed a sensitivity analysis on the studies investigating serum/plasma ADH levels in Psychosis, which seemed to confirm that the extraction technique could have had an effect on the…”
May oxytocin be a trait marker for bipolar disorder?
Turan, T., Uysal, C., Asdemir, A., & Kılıç, E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.07.017 · Cited by 66 · cited 2× · see citing works
“, 2013), bipolar disorder (BD) (Rubin et al., 2014; Turan et al., 2013), major depressive disorder (MDD) (Goldstein et al.”
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi‐Nazarloo, H., Harris, M. S. H., Hill, S. K., Reilly, J. L., & Sweeney, J. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.019 · Cited by 65 · see citing works
Pagel, T., Baldessarini, R. J., Franklin, J. G., & Baethge, C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12057 · Cited by 64 · cited 2× · see citing works
“…example, despite evidence that patients with schizoaffective psychoses may have clear distinctive features as compared to schizophrenic psychoses (Pagel et al., 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014,…”
Taurines, R., Schwenck, C., Lyttwin, B., Schecklmann, M., Jans, T., Reefschläger, L., Geissler, J. M., Gerlach, M., & Romanos, M. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0145-y · Cited by 61 · see citing works
Frank, G., Kaye, W. H., Altemus, M. M., & Greeno, C. G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00243-2 · Cited by 60 · cited 5× · see citing works
“A comprehensive systematic review and preliminary meta-analysis Rutigliano Graziaa,b,1, Rocchetti Matteoa,c,1, Paloyelis Yannisd, Gilleen Jamesa,f, Sardella Albertoa, Cappucciati Marcoa,c, Palombini Erikaa,c, Dell’Osso Lilianab, Caverzasi Edgardoc, Politi Pierluigic, McGuire Philipa, Fusar-Poli Paoloa,e,n a Department…”
InfluentialWalsh, P., Spelman, L., Sharifi, N., & Thakore, J. H. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.11.003 · Cited by 60 · see citing works
Goldman, M. B. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.06.004 · Cited by 60 · cited 2× · see citing works
“It has been argued that psychotic exacerbations may be concurrent with a transient reset of the osmostasis for ADH secretion, elevated plasma levels of the neuropeptide and eventually water imbalance, as an epiphenomenon of dysfunctions in hypothalamic pituitary adrenal (HPA) axis response to psychological stimuli(Gol…”
BackgroundChronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro
Altemus, M. M., Cizza, G., & Gold, P. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)91326-a · Cited by 60 · cited 1× · see citing works
“…al. (1998) 3 / / / / ⋆⋆ / ⋆ / Elman et al. (2003) 5 ⋆ / ⋆ ⋆ / / ⋆ ⋆ Ryan et al. (2004) 6 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ / Walsh et al. (2005) 5 ⋆ / / ⋆ ⋆ ⋆ ⋆ / (b) Rubin et al. (2013) 6 ⋆ ⋆ ⋆ ⋆ ⋆ / ⋆ / (b) Jobst et al. (2014) 4 ⋆ / / / ⋆⋆ / ⋆ / (d) Rubin et al. (2014) 7 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ ⋆ Overall 4.09 (71.814) CSF…”
InfluentialFujisawa, T. X., Tanaka, S., Saito, D. N., Kosaka, H., & Tomoda, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00295 · Cited by 59 · cited 2× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al.,…”
Nomura, S., Ito, T., Yamamoto, E., Sumigama, S., Iwase, A., Okada, M., Shibata, K., Ando, H., Ino, K., Kikkawa, F., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.04.006 · Cited by 58 · cited 1× · see citing works
“Moreover, high levels of oxytocinase secreted by the placenta might further contribute to the final serum/plasma OT levels (Nomura et al., 2005).”
Rubín, R. T., O’Toole, S. M., Rhodes, M. E., Sekula, L. K., & Czambel, R. K. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00085-2 · Cited by 58 · cited 1× · see citing works
“…4 ⋆ / / ⋆ / ⋆ ⋆ / Overall 3.33 (71.155) Plasma/Serum Antidiuretic Hormone in Major Depressive Disorder (b) Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / Inder et al. (1997) 4 ⋆ / / ⋆ / / ⋆ ⋆ van Londen et al. (1998) 4 ⋆ / / ⋆ / / ⋆ ⋆ Rubin et al. (1999) 5 ⋆ / / ⋆ ⋆⋆ / ⋆ / Goldstein et al. (2000) 4…”
InfluentialAntipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients
Raskind, M. A., COURTNEY, N., Murburg, M. M., Backus, F. I., Bokan, J. A., Ries, R. K., Dorsa, D. M., & Weitzman, R. E. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90167-3 · Cited by 56 · cited 2× · see citing works
“Neuroleptics have also been reported to normalise raised ADH plasma levels in patients with schizophrenia (Raskind et al., 1987).”
BackgroundHoge, E. A., Lawson, E. A., Metcalf, C. A., Keshaviah, A. P., Zak, P. J., Pollack, M. H., & Simon, N. M. (2012) · Depression and Anxiety · doi:10.1002/da.21973 · Cited by 56 · cited 4× · see citing works
“We did not perform analyses on diagnoses where there was only one study available: generalized social anxiety (GSAD) (Hoge et al., 2012), borderline personality disorder (BPD) (Bertsch et al., 2013), attention deficit and hyperactivity disorder (ADHD) (Taurines et al., 2014), Tourette syndrome (TS)…”
InfluentialPlasma, salivary, and urinary oxytocin in anorexia nervosa: A pilot study
Hoffman, E. R., Brownley, K. A., Hamer, R. M., & Bulik, C. M. (2012) · Eating Behaviors · doi:10.1016/j.eatbeh.2012.02.004 · Cited by 55 · cited 2× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al.,…”
Walss‐Bass, C., Fernandes, J. M., Roberts, D. L., Service, H. M., & Velligan, D. I. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.003 · Cited by 52 · cited 3× · see citing works
“, 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014, 2013, 2010; Strauss et al., 2015; Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al.”
Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia
Strauss, G. P., Keller, W. R., Koenig, J. I., Gold, J. M., Frost, K. H., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.034 · Cited by 51 · cited 2× · see citing works
“, 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014, 2013, 2010; Strauss et al., 2015; Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al.”
Goekoop, J. G., de Winter, R. F. P., de Rijk, R., Zwinderman, K. H., Frankhuijzen-Sierevogel, A. C., & Wiegant, V. M. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.09.003 · Cited by 49 · cited 1× · see citing works
“…Hormone in Major Depressive Disorder (b) Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / Inder et al. (1997) 4 ⋆ / / ⋆ / / ⋆ ⋆ van Londen et al. (1998) 4 ⋆ / / ⋆ / / ⋆ ⋆ Rubin et al. (1999) 5 ⋆ / / ⋆ ⋆⋆ / ⋆ / Goldstein et al. (2000) 4 ⋆ / / / ⋆ / ⋆ ⋆ Goekoop et al. (2006) 3 ⋆ / / / / / ⋆ ⋆ Overall…”
Reduced Plasma Apelin Levels in Patients with Autistic Spectrum Disorder
Boso, M., Emanuele, E., Politi, P., Pace, A., Arra, M., Nemi, S. U. D., & Barale, F. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.08.003 · Cited by 42 · cited 3× · see citing works
“…et al./ Psychiatry R esearch 241 (2016) 207 –220 214 Plasma/Serum Antidiuretic Hormone in Autism Spectrum Disorder (b) Al-Ayadhi (2005) 3 ⋆ / / / ⋆ / ⋆ / Boso et al. (2007) 7 ⋆ / ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ (b) Miller et al. (2013) 4 ⋆ / / / ⋆ / ⋆ ⋆ Overall 4.67 (72.082) Plasma/Serum Antidiuretic Hormone in…”
InfluentialSelf-citationPlasma Levels of Antidiuretic Hormone in Patients Receiving Prolonged Lithium Therapy
Padfield, P. L., Park, S. J., Morton, J. J., et al. (1977) · The British Journal of Psychiatry · doi:10.1192/bjp.130.2.144 · Cited by 38 · cited 2× · see citing works
“R utigliano et al./ Psychiatry R esearch 241 (2016) 207 –220 214 Plasma/Serum Antidiuretic Hormone in Autism Spectrum Disorder (b) Al-Ayadhi (2005) 3 ⋆ / / / ⋆ / ⋆ / Boso et al. (2007) 7 ⋆ / ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ (b) Miller et al. (2013) 4 ⋆ / / / ⋆ / ⋆ ⋆ Overall 4.67 (72.082) Plasma/Serum Antidiuretic Hormone in Bipolar Disord…”
InfluentialNeurohypophyseal Peptides and Psychopathology
Legros, J. J. (2008) · Hormone Research · doi:10.1159/000182396 · Cited by 37 · cited 2× · see citing works
“, 2003), paranoia (Legros et al., 1992), and trust behaviour (Baumgartner et al.”
Impaired osmoregulation in anorexia nervosa: a case-control study
Evrard, F., da Cunha, M. P., Lambert, M. J., & Devuyst, O. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh507 · Cited by 34 · cited 2× · see citing works
“R utigliano et al./ Psychiatry R esearch 241 (2016) 207 –220 214 Plasma/Serum Antidiuretic Hormone in Autism Spectrum Disorder (b) Al-Ayadhi (2005) 3 ⋆ / / / ⋆ / ⋆ / Boso et al. (2007) 7 ⋆ / ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ (b) Miller et al. (2013) 4 ⋆ / / / ⋆ / ⋆ ⋆ Overall 4.67 (72.082) Plasma/Serum Antidiuretic Hormone in Bipolar Disord…”
InfluentialNeuroendocrine Regulation of Lactation and Milk Production
Crowley, W. R. (2015) · Comprehensive physiology · doi:10.1002/j.2040-4603.2015.tb00607.x · Cited by 34 · cited 2× · see citing works
“…ADH and OT have been described as hormones, involved respectively in antidiuresis, osmolality regulation, direct vasoconstriction and hepatic glycogenolysis (Appelgren, 1982; Robertson, 2001) and labor (Husslein, 1984), lactation (Crowley, 2015), and sexual activity (Carmichael et al., 1987).”
Effects of Acute Metabolic Stress on the Peripheral Vasopressinergic System in Schizophrenia
Elman, I., Lukas, S. E., Shoaf, S. E., Rott, D., Adler, C. M., & Breier, A. F. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173014 · Cited by 28 · cited 5× · see citing works
“…/ / / / ⋆ / Overall 2.50 (70.707) Plasma/Serum Antidiuretic Hormone in Psychosis (d) Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / Emsley et al. (1989) 2 / / / / / / ⋆ ⋆ Sarai and Matsunaga (1989) 2 ⋆ / / / / / ⋆ / Ohsawa et al. (1993) 3 ⋆ / / / ⋆ / ⋆ / Kudoh et al. (1998) 3 / / / / ⋆⋆ / ⋆ / Elman et…”
InfluentialWater excretion and plasma vasopressin in psychotic disorders
Emsley, R. A., Potgieter, A., Taljaard, F. J. J., et al. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.250 · Cited by 28 · cited 5× · see citing works
“…(Pagel et al., 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014, 2013, 2010; Strauss et al., 2015; Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al., 1989; Ohsawa et al., 1993; Rubin et al., 2014, 2013)).”
BackgroundInfluentialOxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats
You, Z. D., Li, J. H., Song, C. Y., Lu, C. L., & He, C. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00272-3 · Cited by 23 · cited 1× · see citing works
“As regard OT, preclinical studies in rats found that a systemic injection of lithium leads to a significant elevation of peripheral OT levels (Cui et al., 2001; You et al., 2001).”
BackgroundPathophysiological function of oxytocin secreted by neuropeptides: A mini review
Hashimoto, H., Uezono, Y., & Ueta, Y. (2012) · Pathophysiology · doi:10.1016/j.pathophys.2012.07.005 · Cited by 23 · cited 2× · see citing works
“They are also released in the central nervous system, acting on multiple brain regions as neuromodulators and influencing a range of neurophysiological processes and behaviours (Stoop, 2012), including feeding, anxiety, aggression, social recognition and the stress/fear response to social stimuli (Hashimoto et al., 20…”
Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients
Watson, S., Gallagher, P., Smith, M. S., Young, A. H., & Ferrier, I. N. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.010 · Cited by 23 · cited 2× · see citing works
“, 2014), gene knockout (Wersinger et al., 2002), and viral gene transfer (Pagani et al.”
BackgroundChapter 30 Neurohypophyseal peptides and psychopathology
Legros, J. J., & Ansseau, M. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64589-6 · Cited by 21 · see citing works
Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients
Ohsawa, H., Kishimoto, T., Shimayoshi, N., et al. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03426.x · Cited by 18 · cited 26× · see citing works
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
BackgroundInfluentialKudoh, A., Kudo, M., Ishihara, H., et al. (1998) · Neuropsychobiology · doi:10.1159/000026498 · Cited by 14 · cited 3× · see citing works
“, 2004) investigated peripheral levels of ADH in first-episode, drug naïve patients and eight (Beckmann et al., 1985; Elman et al., 2003; Jobst et al., 2014; Kudoh et al., 1998; Ohsawa et al., 1993; Rubin et al., 2014; Sarai and Matsunaga, 1989; Walsh et al., 2005) in chronic patients.”
BackgroundInfluential[The importance of oxytocin and prostaglandins to the mechanism of labor in humans].
Husslein, P. W. (1984) · PubMed · Cited by 13 · see citing works
ADH secretion in schizophrenic patients on antipsychotic drugs
Sarai, M., & Matsunaga, H. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90082-6 · Cited by 11 · see citing works
Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression
Goldstein, G., Fava, M., Culler, M. D., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00246-8 · Cited by 8 · cited 3× · see citing works
“, 2013), major depressive disorder (MDD) (Goldstein et al., 2000; Ozsoy et al., 2009; Yuen et al., 2014), as well as in anxiety (Hoge et al.”
InfluentialHeuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.-H., Nemeroff, C. B., & Holsboer, F. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)8:2
Flagged first, then by citations
8 of the 148 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999 · see citing works
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
Sikich, L., Kolevzon, A., King, B. H., McDougle, C. J., Sanders, K. B., Kim, S.-J., Spanos, M., Chandrasekhar, T., Trelles, M. D. P., Rockhill, C. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103583 · Cited by 314 · see citing works
Valstad, M., Alvares, G. A., Egknud, M., Matziorinis, A. M., Andreassen, O. A., Westlye, L. T., & Quintana, D. S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.017 · Cited by 277 · see citing works
Kim, J. Y., Son, M. J., Son, C. Y., Radua, J., Eisenhut, M., Gressier, F., Koyanagi, A., Carvalho, A. F., Stubbs, B., Solmi, M., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30181-6 · Cited by 271 · see citing works
Self-citationLee, M. R., Scheidweiler, K. B., Diao, X. X., Akhlaghi, F., Cummins, A., Huestis, M. A., Leggio, L., & Averbeck, B. B. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.27 · Cited by 235 · see citing works
Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers
Leng, G., & Sabatier, N. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12413 · Cited by 237 · see citing works
“A recent systematic review has concluded that studies using ELISA on unex-tracted samples have produced no convincing evidence that peripheral vasopressin or oxytocin might be reliable biomarkers in psychiatric disorders (135).”
BackgroundEvidence-based umbrella review of 162 peripheral biomarkers for major mental disorders
Carvalho, A. F., Solmi, M., Sanches, M., Machado, M. O., Stubbs, B., Ajnakina, O., Sherman, C., Sun, Y. R., Liu, C. S., Brunoni, A. R., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0835-5 · Cited by 204 · see citing works
Self-citationSalivary biomarkers for the diagnosis and monitoring of neurological diseases
Farah, R., Haraty, H., Salame, Z., Fares, Y., Ojcius, D. M., & Sadier, N. S. (2018) · Biomedical Journal · doi:10.1016/j.bj.2018.03.004 · Cited by 170 · see citing works
Advances in human oxytocin measurement: challenges and proposed solutions
Tabak, B. A., Leng, G., Szeto, A., Parker, K. J., Verbalis, J. G., Ziegler, T. E., Lee, M. R., Neumann, I. D., & Mendez, A. J. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01719-z · Cited by 170 · see citing works
“Methodological differences and a lack of standardization across studies of human (and nonhuman animal) endogenous oxytocin concentrations have made it challenging to synthesize our current state of knowledge of the role of oxytocin in human social processes and psychiatric illness [142].”
BackgroundNeural Circuits for Social Cognition: Implications for Autism
Fernández, M. C., Mollinedo-Gajate, I., & Peñagarikano, O. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.07.013 · Cited by 137 · see citing works
“Yet, studies investigating the potential use of OXT as a biochemical biomarker for social dysfunction in ASD have reported mixed results (see Rutigliano et al. 2016 for a review).”
Oxytocin and postpartum depression: A systematic review
Thul, T. A., Corwin, E. J., Carlson, N. S., Brennan, P. A., & Young, L. J. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104793 · Cited by 142 · see citing works
“A recent systematic review has concluded that studies using ELISA on unextracted samples have produced no convincing evidence that peripheral oxytocin might be reliable biomarkers in psychiatric disorders (Rutigliano et al., 2016).”
BackgroundMartin, J., Kagerbauer, S. M., Gempt, J., Podtschaske, A., Hapfelmeier, A., & Schneider, G. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12596 · Cited by 122 · see citing works
Engel, S., Klusmann, H., Ditzen, B., Knaevelsrud, C., & Schumacher, S. (2018) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.11.002 · Cited by 121 · see citing works
Cagna, F. D., Fusar‐Poli, L., Damiani, S., Rocchetti, M., Giovanna, G., Mori, A., Politi, P., & Brondino, N. (2019) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2019.17.1.1 · Cited by 118 · see citing works
Self-citationOxytocin levels tend to be lower in autistic children: A meta-analysis of 31 studies
John, S., & Jaeggi, A. V. (2021) · Autism · doi:10.1177/13623613211034375 · Cited by 103 · see citing works
“To date, only one formal meta-analysis has addressed whether baseline OT levels differ in autistic and neurotypical people (Rutigliano et al., 2016).”
BackgroundResultGenetic, epigenetic, and environmental factors controlling oxytocin receptor gene expression
Danoff, J. S., Wroblewski, K. L., Graves, A. J., Quinn, G. C., Perkeybile, A. M., Kenkel, W. M., Lillard, T. S., Parikh, H. I., Golino, H. F., Gregory, S. G., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01017-5 · Cited by 85 · see citing works
“A common target of efforts to identify biomarkers of psychiatric disorders is the oxytocin system [2].”
BackgroundOxytocin and stress-related disorders: neurobiological mechanisms and treatment opportunities
Sippel, L. M., Allington, C. E., Pietrzak, R. H., Harpaz-Rotem, I., Mayes, L. C., & Olff, M. (2017) · Chronic Stress · doi:10.1177/2470547016687996 · Cited by 99 · see citing works
“A meta-analysis of 64 studies of several psychiatric disorders, including MDD but not PTSD, showed no significant differences in peripheral OT between healthy and psychiatric groups (except in anorexia).(40) Compared with trauma-exposed controls, lower peripheral OT levels have been observed in men, but not women, wit…”
MethodChoir versus solo singing: effects on mood, and salivary oxytocin and cortisol concentrations
Schladt, T. M., Nordmann, G. C., Emilius, R., Kudielka, B. M., de Jong, T. R., & Neumann, I. D. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00430 · Cited by 94 · see citing works
“…in central and peripheral body fluids has become a popular tool with the aim to assess the general activity of the OXT system in both healthy and clinical populations, either at rest or after an experimental challenge (Crockford et al., 2014; de Jong et al., 2015; Rutigliano et al., 2016).”
BackgroundMartins, D., Gabay, A. S., Mehta, M. A., & Paloyelis, Y. (2020) · eLife · doi:10.7554/elife.62456 · Cited by 91 · see citing works
“vary with clinical aspects of disease (Rutigliano et al., 2016).”
BackgroundSelf-citationKing, L., Robins, S., Chen, G., Yerko, V., Zhou, Y., Nagy, C., Feeley, N., Gold, I., Hayton, B. C., Turecki, G., et al. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.09.006 · Cited by 78 · see citing works
“Still, a recent meta-analysis revealed that there were no substantial differences in peripheral OXT levels between psychiatric patients and healthy controls (Rutigliano et al., 2016).”
MECHANISMS IN ENDOCRINOLOGY: Anorexia nervosa and endocrinology: a clinical update
Støving, R. K. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0596 · Cited by 72 · see citing works
Endogenous Oxytocin Levels in Autism—A Meta-Analysis
Moerkerke, M., Peeters, M., de Vries, L. M., Daniëls, N., Steyaert, J. G., Alaerts, K., & Boets, B. (2021) · Brain Sciences · doi:10.3390/brainsci11111545 · Cited by 65 · see citing works
Maulitz, L., Stickeler, E., Stickel, S., Habel, U., Tchaikovski, S. N., & Chechko, N. (2022) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2022.100988 · Cited by 67 · see citing works
Aydın, O., Lysaker, P. H., Balıkçı, K., Ünal‐Aydın, P., & Esen-Danacı, A. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.048 · Cited by 62 · see citing works
What's Love Got to do with it: Role of oxytocin in trauma, attachment and resilience
Sharma, S. R., Gonda, X., Dome, P., & Tarazi, F. I. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107602 · Cited by 61 · see citing works
Bakker-Huvenaars, M. J., Greven, C. U., Herpers, P., Wiegers, E., Jansen, A., van der Steen, R., van Herwaarden, A. E., Baanders, A. N., Nijhof, K. S., Scheepers, F., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.07.097 · Cited by 51 · see citing works
Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives
Giel, K. E., Zipfel, S., & Hallschmid, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171128143158 · Cited by 53 · see citing works
“In patients with bulimia nervosa, no alterations in CSF and circulating oxytocin levels have been found [84, 86, 87, 90-92], while up to now there is to the best of our knowledge no mechanistic study on oxytocin function in patients with binge eating disorder (see also 5.”
BackgroundResultThe endogenous oxytocin system in depressive disorders: A systematic review and meta-analysis
Engel, S., Laufer, S., Knaevelsrud, C., & Schumacher, S. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.11.011 · Cited by 53 · see citing works
Oxytocin secretion is pulsatile in men and is related to social-emotional functioning
Baskaran, C., Plessow, F., Silva, L., Asanza, E., Marengi, D., Eddy, K. T., Sluss, P. M., Johnson, M. L., Misra, M., & Lawson, E. A. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.07.486 · Cited by 50 · see citing works
Schmitt, L., Smith, E. G., Pedapati, E. V., Horn, P. S., Will, M., Lamy, M., Barber, L., Trebley, J., Meyer, K., Heiman, M. L., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-30909-0 · Cited by 49 · see citing works
Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder
Bjørklund, G., Meguid, N. A., El-Ansary, A. K., El‐Bana, M. A., Dadar, M., Aaseth, J., Hemimi, M., Osredkar, J., & Chirumbolo, S. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1192-1 · Cited by 51 · see citing works
Kohlhoff, J. R., Cibralic, S., Hawes, D. J., & Eapen, V. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104573 · Cited by 50 · see citing works
Role of oxytocin in parental behaviour
Olazábal, D. E. (2018) · Journal of Neuroendocrinology · doi:10.1111/jne.12594 · Cited by 47 · see citing works
Aita, C., Mizoguchi, Y., Yamamoto, M., SeguchI, Y., Yatsuga, C., Nishimura, T., Sugimoto, Y., Takahashi, D., Nishihara, R., Ueno, T., et al. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.12.139 · Cited by 44 · see citing works
Ferreira, A. C., & Osório, F. D. L. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110561 · Cited by 47 · see citing works
Leppänen, J., Cardi, V., Ng, K. W., Paloyelis, Y., Stein, D., Tchanturia, K., & Treasure, J. L. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.01.017 · Cited by 46 · see citing works
Self-citationDiagnostic biomarkers for obsessive-compulsive disorder: A reasonable quest or ignis fatuus?
Fullana, M. A., Abramovitch, A., Via, E., López-Sola, C., Goldberg, X., Reina, N., Fortea, L., Solanes, A., Buckley, M. J., Ramella-Cravaro, V., et al. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.08.008 · Cited by 44 · see citing works
Kagerbauer, S. M., Debus, J. M., Martin, J., Gempt, J., Jungwirth, B., Hapfelmeier, A., & Podtschaske, A. H. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.101977 · Cited by 38 · see citing works
Social withdrawal and gender differences: Clinical phenotypes and biological bases
Masi, G., Berloffa, S., Milone, A., & Brovedani, P. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24802 · Cited by 42 · see citing works
Current directions in biomarkers and endophenotypes for anorexia nervosa: A scoping review
Malcolm, A., & Phillipou, A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.063 · Cited by 36 · see citing works
Effects of Intranasal Oxytocin on the Interpretation and Expression of Emotions in Anorexia Nervosa
Leppänen, J., Cardi, V., Ng, K. W., Paloyelis, Y., Stein, D. J., Tchanturia, K., & Treasure, J. L. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12458 · Cited by 40 · see citing works
Self-citationOxytocin release deficit and social cognition in craniopharyngioma patients
Brandi, M., Gebert, D., Kopczak, A., Auer, M. K., & Schilbach, L. (2020) · Journal of Neuroendocrinology · doi:10.1111/jne.12842 · Cited by 34 · see citing works
Rømer, T. B., Jeppesen, R., Christensen, R. H. B., & Benros, M. E. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02059-2 · Cited by 33 · see citing works
Circulating Non-Coding RNAs as a Signature of Autism Spectrum Disorder Symptomatology
Salloum‐Asfar, S., Elsayed, A. K., Elhag, S. F., & Abdulla, S. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126549 · Cited by 34 · see citing works
“A meta-analysis review has recently shown the possibility of using oxytocin and vasopressin as biomarkers; however, this is heterogeneous in psychiatric disorders and does not provide convincing findings that peripheral OT or ADH levels are altered in ASD compared to healthy controls [14].”
BackgroundSelf-mutilation accompanying religious delusions: a case report and review.
Clark, R. (1981) · PubMed · Cited by 34 · see citing works
Plasma oxytocin levels in major depressive and bipolar II disorders
Lien, Y.-J., Chang, H. H., Tsai, H.-C., Yang, Y. K., Lu, R., & Chen, P. S. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.08.080 · Cited by 31 · see citing works
Oxytocin and Facial Emotion Recognition
Ellenbogen, M. A. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_20 · Cited by 33 · see citing works
Yuhi, T., Ise, K., Iwashina, K., Terao, N., Yoshioka, S., Shomura, K., Maehara, T., Yazaki, A., Koichi, K., Furuhara, K., et al. (2018) · Behavioral Sciences · doi:10.3390/bs8110101 · Cited by 39 · see citing works
Morphofunctional Alterations of the Hypothalamus and Social Behavior in Autism Spectrum Disorders
Carìa, A., Ciringione, L., & de Falco, S. (2020) · Brain Sciences · doi:10.3390/brainsci10070435 · Cited by 29 · see citing works
“Altered OT and AVP synthesis and release appear to be among the core dysfunctions underpinning the impairments in social and communication behavior of individuals with ASD [9,11,37], although it remains unclear whether OT neuropeptide can be used as biochemical marker for ASD [38].”
BackgroundChen, Q., Zhuang, J., Zuo, R., Zheng, H., Dang, J., & Wang, Z. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.052 · Cited by 31 · see citing works
Reijnen, A., Geuze, E., & Vermetten, E. H. G. J. M. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2017.06.010 · Cited by 29 · see citing works
BDNF levels are associated with autistic traits in the general population
Brondino, N., Fusar‐Poli, L., Rocchetti, M., Bertoglio, F., Bloise, N., Visai, L., & Politi, P. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.008 · Cited by 27 · see citing works
Self-citationTyszkiewicz‐Nwafor, M., Rybakowski, F., Dmitrzak‐Węglarz, M., Skibińska, M., Paszyńska, E., Dutkiewicz, A., & Słopień, A. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.01032 · Cited by 27 · see citing works
“It is released into the bloodstream, entering peripheral circulation, as well as directly into the nervous system (9).”
BackgroundNeuroendocrine adaptations to starvation
Amorim, T., Khiyami, A. M., Latif, T., & Fazeli, P. K. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106365 · Cited by 26 · see citing works
Bone metabolism in anorexia nervosa and hypothalamic amenorrhea
Chou, S. H.-H., & Mantzoros, C. S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.10.009 · Cited by 28 · see citing works
Szczepanska‐Sadowska, E. K., Wsół, A., Cudnoch‐Jędrzejewska, A., Czarzasta, K., & Żera, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11040908 · Cited by 26 · see citing works
Gerra, M. L., Gerra, G., Mercolini, L., Manfredini, M., Somaini, L., Pieri, C. M., Antonioni, M., Protti, M., Ossola, P., & Marchesi, C. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.005 · Cited by 25 · see citing works
“…et al., 2015), the concern about the lack of neurophysiological evidence of a direct relationship between peripheral levels of oxytocin and its central release and activity, widely expressed in the literature, cannot be ignored also in the interpretation of our findings (Rutigliano et al., 2016).”
BackgroundResultPeripheral Biomarkers of Anorexia Nervosa: A Meta-Analysis
Wu, Y., Watson, H. J., Re, A. C. D., Finch, J. E., Hardin, S. L., Dumain, A. S., Brownley, K. A., & Baker, J. H. (2024) · Nutrients · doi:10.3390/nu16132095 · Cited by 21 · see citing works
Scharner, S., Prinz, P., Goebel‐Stengel, M., Lommel, R., Kobelt, P., Hofmann, T., Rose, M., & Stengel, A. (2017) · Brain Research · doi:10.1016/j.brainres.2017.09.024 · Cited by 23 · see citing works
Kobylinska, L. (2019) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2019.16 · Cited by 20 · see citing works
“Moreover, a meta-analysis on the subject published in 2016, and summarizing the results from 404 patients from 4 clinical trials found no overall differences in the levels of plasma oxytocin between the patients with ASD and the neurotypical controls (29).”
ResultDiscussions and perspectives regarding oxytocin as a biomarker in human investigations
Mera, J. C. C., Molano, M. A. C., López, C. C. G., Triana, C. A., & Cotrina, J. A. M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08289 · Cited by 21 · see citing works
“Some meta-analyses point out that it is not reliable, regardless of the type of sample taken (Rutigliano et al., 2016).”
BackgroundSkinner, J. A., Garg, M. L., Dayas, C. V., Fenton, S., & Burrows, T. L. (2018) · Nutrition Reviews · doi:10.1093/nutrit/nux078 · Cited by 22 · see citing works
“05).(37) There is some evidence to suggest that over the course of recovery from AN the oxytocin system returns to normal levels.”
BackgroundFujioka, T., Fujisawa, T. X., Inohara, K., Okamoto, Y., Matsumura, Y., Tsuchiya, K. J., Katayama, T., Munesue, T., Tomoda, A., Wada, Y., et al. (2020) · Annals of General Psychiatry · doi:10.1186/s12991-020-00287-2 · Cited by 20 · see citing works
Endogenous Oxytocin Release Eliminates In-Group Bias in Monetary Transfers With Perspective-Taking
Terris, E. T., Beavin, L. E., Barraza, J. A., Schloss, J., & Zak, P. J. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00035 · Cited by 19 · see citing works
“Commercially available immunoassays have been questioned on their validity due to high variability (e.g., McCullough et al., 2013; Christensen et al., 2014; Rutigliano et al., 2016).”
BackgroundOxytocin and vasopressin in the hippocampus
Zăgrean, A., Georgescu, I.-A., Ieșanu, M. I., Ionescu, R.-B., Haret, R. M., Panaitescu, A. M., & Zăgrean, L. (2022) · Vitamins and hormones · doi:10.1016/bs.vh.2021.11.002 · Cited by 20 · see citing works
Hidalgo‐Figueroa, M., Salazar, A., Romero-López-Alberca, C., MacDowell, K. S., García‐Bueno, B., Bioque, M., Bernardo, M., Parellada, M., González-Pinto, A. M., García‐Portilla, M. P., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac023 · Cited by 20 · see citing works
“However, a recent meta-analysis found no robust evidence of alterations to oxytocin in cases of psychosis, possibly reflecting the heterogeneity of these studies and indicating that more analyses are needed to define oxytocin as a biomarker for a FEP (Rutigliano et al., 2016).”
ResultMarincowitz, C., Koen, N., Löchner, C., & Stein, D. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00012-5 · Cited by 19 · see citing works
Agorastos, A., Sommer, A., Heinig, A., Wiedemann, K., & Demiralay, C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00453 · Cited by 17 · see citing works
“The co-secreted and synergistically at this level acting CRH and AVP cannot be simply measured because of their pulsatile secretion pattern, small molecular size, avid binding to platelets, rapid plasma clearance, degradation, and instability (28, 29).”
BackgroundMolecular Mechanisms of Aberrant Neuroplasticity in Autism Spectrum Disorders (Review)
Anashkina, A. A., & Erlykina, E. I. (2021) · Современные технологии в медицине · doi:10.17691/stm2021.13.1.10 · Cited by 18 · see citing works
“[111] came to the conclusion that vasopressin preparations may be promising for communicability improvement, however, they noted inconsistency of data in various studies about the role of vasopressin in ASD development.”
ResultHidese, S., Yoshida, F., Ishida, I., Matsuo, J., Hattori, K., & Kunugi, H. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12304 · Cited by 16 · see citing works
Fang, A., Jacoby, R. J., Beatty, C. C., Germine, L. T., Plessow, F., Wilhelm, S., & Lawson, E. A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104541 · Cited by 17 · see citing works
“…may play a role in the pathophysiology of BDD. Oxytocin has also been implicated as a candidate biomarker of certain psychiatric disorders associated with BDD, such as psychosis, depression, anxiety disorders, and eating disorders, although the evidence has been mixed (Rutigliano et al., 2016).”
BackgroundChapter 4. Psychoneuroendocrinology
Sforzini, L., Weston, F. I., & Pariante, C. M. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as04 · Cited by 16 · see citing works
Veiga, L., Carolino, E., Santos, I., Veríssimo, C., Almeida, A., Grilo, A. M., Brito, M., & Santos, C. (2022) · BMC Psychology · doi:10.1186/s40359-022-00744-5 · Cited by 17 · see citing works
“However, a recent meta-analysis that include 64 studies with several psychiatric disorders, showed no significant differences in peripheral OT between a healthy adult and the MDD groups [33].”
Developments in the discovery and design of intranasal antidepressants
Panek, M., Kawalec, P., Pilc, A., & Lasoń, W. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1776697 · Cited by 16 · see citing works
Individual differences in social homeostasis
Bales, K. L., Hang, S., Paulus, J. P., Jahanfard, E., Manca, C., Jost, G. M., Boyer, C. J., Bern, R., Yerumyan, D., Rogers, S., et al. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1068609 · Cited by 13 · see citing works
“, 2001), while others have found no relationship or altered correlations to symptoms (Rutigliano et al., 2016).”
BackgroundThe use of intranasal oxytocin in the treatment of eating disorders
Malewska-Kasprzak, M., Jowik, K., & Tyszkiewicz‐Nwafor, M. (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102387 · Cited by 13 · see citing works
“…(BN) have been observed for years, as well as a different pattern of postprandial OXT secretion, correlating, among other things, with the level of depressive and anxiety symptoms (Maguire et al., 2013; Rutigliano et al., 2016; Monteleone et al., 2016; Lawson et al., 2012; Lawson et al., 2011).”
Intranasal oxytocin in a genetic animal model of autism
Szabó, J., Mlynár, M., Feješ, A., Renczés, E., Borbélyová, V., Ostatníková, D., & Celec, P. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02330-6 · Cited by 13 · see citing works
“Furthermore, some studies have found that children suffering from ASD have lower concentrations of circulating OXT [8] and they were shown to be associated with annotated ASD risk genes [9].”
BackgroundKagerbauer, S. M., Martin, J., Ulm, B., Jungwirth, B., & Podtschaske, A. H. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12797 · Cited by 12 · see citing works
Guo, H., Tang, L., He, M., Tang, W., Liu, J., Wu, S., Yuan, S., Wang, J., & Tang, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1681060 · Cited by 15 · see citing works
Borland, J. M. (2025) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2025.101175 · Cited by 12 · see citing works
Hohl, C. H., Zilcha‐Mano, S., & Delgadillo, J. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105935 · Cited by 12 · see citing works
“…role in regulating cognitive, emotional and behavioral responses to social stimuli, there has been increasing interest in the potential relevance of oxytocin regarding psychopathology (see reviews by Cochran et al., 2013; Rutigliano et al., 2016; Engel et al., 2019; John and Jaeggi, 2021).”
BackgroundGenetic influences of autism candidate genes on circuit wiring and olfactory decoding
Hartig, R., Wolf, D., Schmeißer, M. J., & Kelsch, W. (2021) · Cell and Tissue Research · doi:10.1007/s00441-020-03390-8 · Cited by 11 · see citing works
“1 3 2020), and potentially also in human ASD cases (Husarova et al. 2016; Rutigliano et al. 2016; Zhang et al. 2016).”
BackgroundPeripheral Oxytocin Predicts Higher-Level Social Cognition in Men Regardless of Empathy Quotient
Deuse, L., Wudarczyk, O. A., Rademacher, L., Kaleta, P., Karges, W., Kacheva, S., Gründer, G., & Lammertz, S. E. (2018) · Pharmacopsychiatry · doi:10.1055/a-0590-4850 · Cited by 11 · see citing works
“According to a recent meta-analysis [67], which combined currently available data from a total of 556 participants and corrected effect sizes for publication bias, the OT deficiency hypothesis in autism lacks solid evidence.”
MethodAzadbakht, A., Salehi, M., Maracy, M. R., & Banafshe, H. R. (2022) · European Addiction Research · doi:10.1159/000525443 · Cited by 10 · see citing works
Goetze, J. P., & Støving, R. K. (2020) · Brain and Behavior · doi:10.1002/brb3.1551 · Cited by 10 · see citing works
“Different subtypes of ADH receptors have been detected not only in the hypothalamus, but also in the cerebral cortex and the hippocampus where it may be involved in responses to stress, depression, and anxiety (Rutigliano et al., 2016).”
BackgroundOxytocin, vasopressin and trust: Associations with aggressive behavior in healthy young males
Berends, Y. R., Tulen, J. H. M., Wierdsma, A. I., PELT, J. V., Kushner, S. A., & Marle, H. J. C. V. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.02.027 · Cited by 11 · see citing works
Crucianelli, L., Serpell, L., Paloyelis, Y., Ricciardi, L., Robinson, P. H., Jenkinson, P. M., & Fotopoulou, A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024913 · Cited by 9 · see citing works
“Patients with AN have reduced central ([12]; see [13] for a systematic review and meta-analysis) and peripheral level [14] of OT at baseline and in response to stimulation with estrogens [15].”
BackgroundSelf-citationPsychoneuroendocrinology and Clinical Psychology
Fischer, S., & Ehlert, U. (2019) · Clinical Psychology in Europe · doi:10.32872/cpe.v1i2.33030 · Cited by 10 · see citing works
“On the oth‐ er hand, peripheral levels of oxytocin are often found to be unaltered in the same patients as well as in patients with psychotic disorders (Rutigliano et al., 2016).”
BackgroundBerends, Y. R., Tulen, J. H. M., Wierdsma, A. I., PELT, J. V., Feldman, R., Zagoory‐Sharon, O., de Rijke, Y. B., Kushner, S. A., & Marle, H. J. C. V. (2021) · Journal of Forensic Psychiatry and Psychology · doi:10.1080/14789949.2021.1985158 · Cited by 7 · see citing works
“For urinary levels insufficient data are available to draw further conclusions (Rutigliano et al., 2016; Valstad et al., 2017).”
BackgroundDeciphering autism heterogeneity: a molecular stratification approach in four mouse models
Gora, C., Dudas, A., Vaugrente, O., Drobecq, L., Pecnard, E., Lefort, G., & Pellissier, L. P. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03113-5 · Cited by 9 · see citing works
Oxytocin for the treatment of autism spectrum disorder in children
Griffiths, J. L., Mishaal, R. A., Nabetani, M., & Goldman, R. D. (2022) · Canadian Family Physician · doi:10.46747/cfp.6802103 · Cited by 7 · see citing works
Hidalgo‐Figueroa, M., Salazar, A., Romero-López-Alberca, C., et al. (2023) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyad051 · Cited by 7 · see citing works
Oxytocin and eating disorders: Knowledge gaps and future directions
Russell, J. D., & Hunt, G. E. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106290 · Cited by 7 · see citing works
Preliminary Insights in Oxytocin Association with the Onset of Diabetic Neuropathy
Kobylinska, L. (2017) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2017.249 · Cited by 7 · see citing works
Tololeski, B. P., Grabner, A. S., & Kumperščak, H. G. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.686030 · Cited by 6 · see citing works
“A correlation between peripheral levels and central activity is still questionable (104).”
BackgroundResultSalivary oxytocin after oxytocin administration: Examining the moderating role of childhood trauma
Fragkaki, I., Glennon, J. C., & Cima, M. (2020) · Biological Psychology · doi:10.1016/j.biopsycho.2020.107903 · Cited by 6 · see citing works
“Extensive research has explored the potential role of peripheral oxytocin levels as a biomarker of several psychiatric disorders, but the findings so far do not support this hypothesis (Rutigliano et al., 2016).”
BackgroundThe association between salivary oxytocin, age, and puberty in children with and without OCD
Mora‐Jensen, A. C., Clemmensen, L. K. H., Grønberg, M. G., Lebowitz, E. R., Quintana, D. S., Jørgensen, N. R., Larsen, C. S., Bak, L. K., Christensen, G. L., Pretzmann, L., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-80194-8 · Cited by 5 · see citing works
“A meta-analysis pooling the two aforementioned studies in adults also found no significant difference 29 , however, a more recent meta-analysis also including the study by Marazziti et al., found significantly higher levels in patients with OCD compared to healthy controls 30 .”
Salivary oxytocin after play with parents predicts behavioural problems in preschool children
Torres, N., Martins, D., Monteiro, L., dos Santos, A. J., Vaughn, B. E., & Veríssimo, M. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105609 · Cited by 5 · see citing works
Oxytocin testing and reproductive health: Status and clinical applications
Gruson, D. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.10.016 · Cited by 5 · see citing works
Goulter, N., Kaouar, S., & Kimonis, E. R. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106259 · Cited by 4 · see citing works
“Researchers have also failed to agree whether oxytocin is a reliable correlate of psychiatric constructs (Rutigliano et al., 2016), likely due to its pulsatile release (i.e., a pulse every 3 – 5 min, not continuous release) into the periphery that complicates measurement and increases the…”
- Authors
- Rutigliano, G., Rocchetti, M., Paloyelis, Y., Gilleen, J., Sardella, A., Cappucciati, M., Palombini, E., Dell’Osso, L., Caverzasi, E., Politi, P., McGuire, P., & Fusar-Poli, P.
- Affiliations
- University of Pisa (IT)
- King's College London (GB)
- University of Pavia (IT)
- ORCID
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 241
- Pages
- 207-220
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W2346907797
- Semantic Scholar
- b0170825c65f1ff6ded651e1a64ce45a933e7750
- Cited by
- 149
- References
- 148
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 11 · 2023: 15 · 2022: 19 · 2021: 17 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 19 · 2016: 3
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychiatry Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- ESRC (ES/K009400/1)
- NARSAD
- Topics
- Social Sciences › Psychology › Social Psychology › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- vasopressin, biomarkers, mental illness, saliva, plasma, serum, cerebrospinal fluid, urine, anorexia nervosa, methodological heterogeneity, study quality
- MeSH terms
- Mental Disorders, Humans, Oxytocin, Vasopressins, Reproducibility of Results, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-08.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-08.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review